{"doc_id": 0, "doc": {"person_id": 115967197, "visit_occurrence_id": 109834825, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2017-10-09 00:00:00", "visit_end_datetime": "2017-10-09 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-09 00:00:00, ended at 2017-10-09 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- First trimester pregnancy\n- High risk pregnancy\n- Illness\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 92, "patient_first_visit_date": "2012-10-05 14:12:00", "patient_last_visit_date": "2021-03-30 16:05:00", "end_obs_date": "2018-10-09", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 7, "cumulated_visit_num": 7, "cumulated_approximate_token_count": 4962, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-10-05 14:12:00, ended at 2012-10-07 09:35:00\nThe patient in this visit was 31 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 12.51 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.0 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.29 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Prothrombin time (PT): 14.1 (second)\n- Body height: 5' 2\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.40 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.0 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 268 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n- Laparoscopic cholecystectomy\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Laparoscopy, surgical; cholecystectomy\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Cholelithiasis AND cholecystitis without obstruction\n- Gallbladder calculus with acute cholecystitis and no obstruction\n- Right upper quadrant pain\n- Epigastric pain\n- Primary diagnosis: Acute cholecystitis\n- Leukocytosis\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-10-06, presumably until 2012-10-06\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2012-10-05, presumably until 2012-10-06\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2012-10-05, presumably until 2012-10-05\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2012-10-06, presumably until 2012-10-06\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-10-07, presumably until 2013-10-07, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2012-10-06, presumably until 2012-10-07\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2012-10-05, presumably until 2012-10-05\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2012-10-05, presumably until 2012-10-06\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-10-05, presumably until 2012-10-05\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2012-10-05, presumably until 2012-10-06\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2012-10-07, presumably until 2013-04-05, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain.\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2012-10-05, presumably until 2012-10-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2012-10-06 00:00:00, ended at 2012-10-06 00:00:00\nThe patient in this visit was 31 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2012-10-06, presumably until 2012-10-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2016-11-12 00:00:00, ended at 2016-11-12 00:00:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: 34192 (milli-international unit per milliliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.10 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.44 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.85 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 296 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2016-11-12 13:39:00, ended at 2016-11-12 16:12:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.3 (percent)\n- MCV [Entitic volume] by Automated count: 85.9 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.85 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 296 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.44 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.10 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: 34192 (milli-international unit per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n\n### Procedure\n- Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation\n- Collection of venous blood by venipuncture\n- Ultrasound, pregnant uterus, real time with image documentation, transvaginal\n\n### Condition\n- Primary diagnosis: Threatened miscarriage\n- First trimester pregnancy\n- Genitourinary tract hemorrhage\n- Gestation period, 8 weeks\n- Spotting per vagina in pregnancy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-09-15 00:00:00, ended at 2017-09-15 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 200 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.5 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 307 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.49 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.4 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-09-15 20:29:00, ended at 2017-09-15 22:41:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.4 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 200 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.49 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 307 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Gestation less than 9 weeks\n- Primary diagnosis: Mild hyperemesis gravidarum\n- Vomiting\n- Nausea\n\n### Drug\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2017-09-15, presumably until 2018-09-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Nausea (nausea or vomiting)\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-09-15, presumably until 2017-09-15\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2017-09-15, presumably until 2017-09-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-09 00:00:00, ended at 2017-10-09 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- First trimester pregnancy\n- High risk pregnancy\n- Illness\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Hyperlipidemia within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-10-05 14:12:00, ended at 2012-10-07 09:35:00\nThe patient in this visit was 31 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 12.51 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.0 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.29 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Prothrombin time (PT): 14.1 (second)\n- Body height: 5' 2\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.40 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.0 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 268 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n- Laparoscopic cholecystectomy\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Laparoscopy, surgical; cholecystectomy\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Cholelithiasis AND cholecystitis without obstruction\n- Gallbladder calculus with acute cholecystitis and no obstruction\n- Right upper quadrant pain\n- Epigastric pain\n- Primary diagnosis: Acute cholecystitis\n- Leukocytosis\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-10-06, presumably until 2012-10-06\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2012-10-05, presumably until 2012-10-06\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2012-10-05, presumably until 2012-10-05\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2012-10-06, presumably until 2012-10-06\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-10-07, presumably until 2013-10-07, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2012-10-06, presumably until 2012-10-07\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2012-10-05, presumably until 2012-10-05\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2012-10-05, presumably until 2012-10-06\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-10-05, presumably until 2012-10-05\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2012-10-05, presumably until 2012-10-06\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2012-10-07, presumably until 2013-04-05, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain.\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2012-10-05, presumably until 2012-10-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2012-10-06 00:00:00, ended at 2012-10-06 00:00:00\nThe patient in this visit was 31 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2012-10-06, presumably until 2012-10-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2016-11-12 00:00:00, ended at 2016-11-12 00:00:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: 34192 (milli-international unit per milliliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.10 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.44 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.85 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 296 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2016-11-12 13:39:00, ended at 2016-11-12 16:12:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.3 (percent)\n- MCV [Entitic volume] by Automated count: 85.9 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.85 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 296 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.44 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.10 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: 34192 (milli-international unit per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n\n### Procedure\n- Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation\n- Collection of venous blood by venipuncture\n- Ultrasound, pregnant uterus, real time with image documentation, transvaginal\n\n### Condition\n- Primary diagnosis: Threatened miscarriage\n- First trimester pregnancy\n- Genitourinary tract hemorrhage\n- Gestation period, 8 weeks\n- Spotting per vagina in pregnancy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-09-15 00:00:00, ended at 2017-09-15 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 200 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.5 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 307 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.49 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.4 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-09-15 20:29:00, ended at 2017-09-15 22:41:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.4 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 200 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.49 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 307 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Gestation less than 9 weeks\n- Primary diagnosis: Mild hyperemesis gravidarum\n- Vomiting\n- Nausea\n\n### Drug\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2017-09-15, presumably until 2018-09-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Nausea (nausea or vomiting)\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-09-15, presumably until 2017-09-15\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2017-09-15, presumably until 2017-09-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-09 00:00:00, ended at 2017-10-09 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- First trimester pregnancy\n- High risk pregnancy\n- Illness\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Hyperlipidemia within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of hyperlipidemia means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "6d2f9f268c6962869346308bbd248a7d0d974b3a3874000cc068eb9db775e4a9", "prompt_hash": "b5861d39bacab4dfe4e9239545cf405913a259bb793859c8b36fd21aec84d5ac", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 1, "doc": {"person_id": 115967248, "visit_occurrence_id": 83162915, "death_date": null, "visit_concept_name": "Emergency Room Visit", "visit_start_datetime": "2016-03-02 21:37:00", "visit_end_datetime": "2016-03-02 22:37:00", "visit_length_in_hours": 1.0, "integrated_visit_record": "## Visit\nThis visit record, was from Emergency Room Visit, started at 2016-03-02 21:37:00, ended at 2016-03-02 22:37:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Unsteady when standing\n- Electrocardiogram abnormal\n- Dizziness and giddiness\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 152, "patient_first_visit_date": "2008-06-25 16:50:00", "patient_last_visit_date": "2017-10-04 22:47:00", "end_obs_date": "2017-03-02", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 3, "cumulated_visit_num": 3, "cumulated_approximate_token_count": 1260, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room Visit, started at 2008-06-25 16:50:00, ended at 2008-06-25 23:57:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.66 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.91 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 242 (thousand per microliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.55 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in limb\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-09-04 10:34:00, ended at 2011-09-04 16:48:00\nThe patient in this visit was 59 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.02 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood: 39 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 13.3 (gram per deciliter)\n- Sodium [Moles/volume] in Blood: 142 (millimole per liter)\n- Potassium [Moles/volume] in Blood: 3.5 (millimole per liter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Computed tomography, head or brain; without contrast material\n\n### Condition\n- Diarrhea\n- Essential hypertension\n- Dizziness and giddiness\n- Abnormal results function studies of central nervous system\n- Disorder of brain\n\n### Drug\n- lisinopril 10 MG Oral Tablet, through Oral route, started on 2011-09-04, presumably until 2011-09-04\n- meclizine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2011-09-04, presumably until 2011-10-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 4 times a day as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2016-03-02 21:37:00, ended at 2016-03-02 22:37:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Unsteady when standing\n- Electrocardiogram abnormal\n- Dizziness and giddiness\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Hyperlipidemia within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2008-06-25 16:50:00, ended at 2008-06-25 23:57:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.66 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.91 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 242 (thousand per microliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.55 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in limb\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-09-04 10:34:00, ended at 2011-09-04 16:48:00\nThe patient in this visit was 59 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.02 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood: 39 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 13.3 (gram per deciliter)\n- Sodium [Moles/volume] in Blood: 142 (millimole per liter)\n- Potassium [Moles/volume] in Blood: 3.5 (millimole per liter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Computed tomography, head or brain; without contrast material\n\n### Condition\n- Diarrhea\n- Essential hypertension\n- Dizziness and giddiness\n- Abnormal results function studies of central nervous system\n- Disorder of brain\n\n### Drug\n- lisinopril 10 MG Oral Tablet, through Oral route, started on 2011-09-04, presumably until 2011-09-04\n- meclizine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2011-09-04, presumably until 2011-10-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 4 times a day as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2016-03-02 21:37:00, ended at 2016-03-02 22:37:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Unsteady when standing\n- Electrocardiogram abnormal\n- Dizziness and giddiness\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Hyperlipidemia within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of hyperlipidemia means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "a7aaf8e246a3799cc81c0540fd814dc124fa861f0b2def151e70218d38d14ed1", "prompt_hash": "4b54c8b52a0646645fd33fe5a9f2b7e843a98f1d40e7ee083bf33c87102db065", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 2, "doc": {"person_id": 115967631, "visit_occurrence_id": 150348663, "death_date": null, "visit_concept_name": "Office Visit", "visit_start_datetime": "2020-02-09 08:42:20", "visit_end_datetime": "2020-02-09 09:51:28", "visit_length_in_hours": 1.1522222222222223, "integrated_visit_record": "## Visit\nThis visit record, was from Office Visit, started at 2020-02-09 08:42:20, ended at 2020-02-09 09:51:28\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Behavioral and qualitative analysis of voice and resonance\n\n### Condition\n- Dysphonia\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 89, "patient_first_visit_date": "2016-06-20 10:15:08", "patient_last_visit_date": "2022-04-17 13:33:28", "end_obs_date": "2021-02-08", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 15, "cumulated_visit_num": 15, "cumulated_approximate_token_count": 3258, "visit_cumulated": "## Visit\nThis visit record, was from Office Visit, started at 2016-06-20 10:15:08, ended at 2016-06-20 11:17:07\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-23 14:42:04, ended at 2017-02-23 14:51:19\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- escitalopram 10 MG Oral Tablet, through Oral route, presumably until 2022-04-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- buspirone hydrochloride 5 MG Oral Tablet, through Oral route, presumably until 2022-04-17, with intended 0 refill(s). Instructions: take 5 mg by mouth every day\n- topiramate 100 MG Oral Tablet, through Oral route, presumably until 2022-04-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-06-09 00:00:00, ended at 2017-06-09 00:00:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.46 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.42 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.86 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.8 (percent)\n- MCH [Entitic mass] by Automated count: 27.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 40.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 219 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 82.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-06-09 04:42:00, ended at 2017-06-09 06:53:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 82.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.2 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.86 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.46 (million per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.42 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 40.6 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 219 (thousand per microliter)\n\n### Procedure\n- Ultrasound, transvaginal\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Hypokalemia\n- Disorder of female genital organs\n- Primary diagnosis: Loss of consciousness\n- Pain in pelvis\n\n### Drug\n- ibuprofen 800 MG Oral Tablet, through Oral route, started on 2017-06-09, presumably until 2018-06-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2017-06-09, presumably until 2017-12-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-07-26 18:26:35, ended at 2017-07-26 19:35:57\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dysmenorrhea\n\n### Drug\n- 24 HR naproxen 750 MG Extended Release Oral Tablet, through Oral route, started on 2017-07-26, presumably until 2017-07-26, with intended 1 refill(s). Instructions: take 1 Tab by mouth as directed Take one tab Q 4-8 hrs with meals\n- naproxen 500 MG Oral Tablet, through Oral route, started on 2017-07-26, presumably until 2018-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-06 08:50:06, ended at 2017-08-06 09:46:35\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Insertion of intrauterine device (IUD)\n\n### Condition\n- Dysmenorrhea\n\n### Drug\n- levonorgestrel 0.000833 MG/HR Intrauterine System, through Intrauterine route, started on 2017-08-06, presumably until 2017-08-06, with intended 0 refill(s). Instructions: 1 Intra Uterine Device by Intrauterine route One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-25 17:22:19, ended at 2017-09-25 17:58:47\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Dysmenorrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-01 15:04:35, ended at 2018-02-01 15:37:40\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Generalized abdominal pain\n\n### Drug\n- levonorgestrel 0.000833 MG/HR Intrauterine System, through Intrauterine route, with intended 0 refill(s). Instructions: 1 Device by Intrauterine route One Time\n- hyoscyamine sulfate 0.125 MG Sublingual Tablet, through Oral route, started on 2018-02-01, presumably until 2022-04-17, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed (pain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-04 12:44:38, ended at 2018-04-04 13:41:52\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Inflammation of cervix\n- Primary diagnosis: Pain in pelvis\n\n### Drug\n- naproxen 500 MG Oral Tablet, through Oral route, started on 2018-04-04, presumably until 2019-04-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-25 08:06:00, ended at 2018-04-25 23:59:00\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, transvaginal\n- Ultrasound, pelvic (nonobstetric), real time with image documentation; complete\n\n### Condition\n- Pain in pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-28 16:36:46, ended at 2018-05-28 17:51:40\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dysmenorrhea\n- Premenstrual tension syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-08 09:11:00, ended at 2019-07-08 23:59:00\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Allergic rhinitis due to pollen\n- Cough\n- Abnormal breathing\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-08-11 08:30:00, ended at 2019-08-11 23:59:00\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-30 08:07:36, ended at 2019-12-30 08:57:56\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Laryngoscopy, flexible or rigid telescopic, with stroboscopy\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- clarithromycin 500 MG Oral Tablet, started on 2019-12-02, presumably until 2022-04-17, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-09 08:42:20, ended at 2020-02-09 09:51:28\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Behavioral and qualitative analysis of voice and resonance\n\n### Condition\n- Dysphonia\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Hyperlipidemia within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-06-20 10:15:08, ended at 2016-06-20 11:17:07\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-23 14:42:04, ended at 2017-02-23 14:51:19\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- escitalopram 10 MG Oral Tablet, through Oral route, presumably until 2022-04-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- buspirone hydrochloride 5 MG Oral Tablet, through Oral route, presumably until 2022-04-17, with intended 0 refill(s). Instructions: take 5 mg by mouth every day\n- topiramate 100 MG Oral Tablet, through Oral route, presumably until 2022-04-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-06-09 00:00:00, ended at 2017-06-09 00:00:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.46 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.42 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.86 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.8 (percent)\n- MCH [Entitic mass] by Automated count: 27.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 40.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 219 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 82.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-06-09 04:42:00, ended at 2017-06-09 06:53:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 82.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.2 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.86 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.46 (million per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.42 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 40.6 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 219 (thousand per microliter)\n\n### Procedure\n- Ultrasound, transvaginal\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Hypokalemia\n- Disorder of female genital organs\n- Primary diagnosis: Loss of consciousness\n- Pain in pelvis\n\n### Drug\n- ibuprofen 800 MG Oral Tablet, through Oral route, started on 2017-06-09, presumably until 2018-06-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2017-06-09, presumably until 2017-12-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-07-26 18:26:35, ended at 2017-07-26 19:35:57\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dysmenorrhea\n\n### Drug\n- 24 HR naproxen 750 MG Extended Release Oral Tablet, through Oral route, started on 2017-07-26, presumably until 2017-07-26, with intended 1 refill(s). Instructions: take 1 Tab by mouth as directed Take one tab Q 4-8 hrs with meals\n- naproxen 500 MG Oral Tablet, through Oral route, started on 2017-07-26, presumably until 2018-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-06 08:50:06, ended at 2017-08-06 09:46:35\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Insertion of intrauterine device (IUD)\n\n### Condition\n- Dysmenorrhea\n\n### Drug\n- levonorgestrel 0.000833 MG/HR Intrauterine System, through Intrauterine route, started on 2017-08-06, presumably until 2017-08-06, with intended 0 refill(s). Instructions: 1 Intra Uterine Device by Intrauterine route One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-25 17:22:19, ended at 2017-09-25 17:58:47\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Dysmenorrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-01 15:04:35, ended at 2018-02-01 15:37:40\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Generalized abdominal pain\n\n### Drug\n- levonorgestrel 0.000833 MG/HR Intrauterine System, through Intrauterine route, with intended 0 refill(s). Instructions: 1 Device by Intrauterine route One Time\n- hyoscyamine sulfate 0.125 MG Sublingual Tablet, through Oral route, started on 2018-02-01, presumably until 2022-04-17, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed (pain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-04 12:44:38, ended at 2018-04-04 13:41:52\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Inflammation of cervix\n- Primary diagnosis: Pain in pelvis\n\n### Drug\n- naproxen 500 MG Oral Tablet, through Oral route, started on 2018-04-04, presumably until 2019-04-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-25 08:06:00, ended at 2018-04-25 23:59:00\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, transvaginal\n- Ultrasound, pelvic (nonobstetric), real time with image documentation; complete\n\n### Condition\n- Pain in pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-28 16:36:46, ended at 2018-05-28 17:51:40\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dysmenorrhea\n- Premenstrual tension syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-08 09:11:00, ended at 2019-07-08 23:59:00\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Allergic rhinitis due to pollen\n- Cough\n- Abnormal breathing\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-08-11 08:30:00, ended at 2019-08-11 23:59:00\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-30 08:07:36, ended at 2019-12-30 08:57:56\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Laryngoscopy, flexible or rigid telescopic, with stroboscopy\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- clarithromycin 500 MG Oral Tablet, started on 2019-12-02, presumably until 2022-04-17, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-09 08:42:20, ended at 2020-02-09 09:51:28\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Behavioral and qualitative analysis of voice and resonance\n\n### Condition\n- Dysphonia\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Hyperlipidemia within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of hyperlipidemia means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "5cefe9f6ed6138e55c0ad34b9fc0be2eded1bcdcfd679bf96c62573b41e4726e", "prompt_hash": "c28c8ec4d5653578a5a056bb41028fe9863d490c111cd5a09832c5b64920f585", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 3, "doc": {"person_id": 115967662, "visit_occurrence_id": 74340640, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2015-05-29 10:01:00", "visit_end_datetime": "2015-05-29 23:59:00", "visit_length_in_hours": 13.966666666666667, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-29 10:01:00, ended at 2015-05-29 23:59:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n- Radiologic examination, pelvis; 1 or 2 views\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 109, "patient_first_visit_date": "2014-04-02 10:22:59", "patient_last_visit_date": "2016-06-18 12:52:51", "end_obs_date": "2016-05-28", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 12, "cumulated_visit_num": 12, "cumulated_approximate_token_count": 3578, "visit_cumulated": "## Visit\nThis visit record, was from Office Visit, started at 2014-04-02 10:22:59, ended at 2014-04-02 12:04:14\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- Radiologic examination, pelvis; 1 or 2 views\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of pelvis\n\n### Drug\n- naproxen sodium 220 MG Oral Tablet, through Oral route, presumably until 2014-05-10. Instructions: take  by mouth 2 times a day as needed.\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route. Instructions: take 20 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-04-02 10:23:00, ended at 2014-04-02 23:59:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, pelvis; 1 or 2 views\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n\n### Condition\n- Degenerative joint disease of pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-10 09:30:27, ended at 2014-05-10 11:18:23\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Pre-surgery evaluation\n\n### Condition\n- Diverticulitis of colon\n- Primary diagnosis: Joint pain of pelvic region\n- Congenital deformity of hip joint\n- Gastroesophageal reflux disease\n- Restless legs\n\n### Drug\n- naproxen sodium 220 MG Oral Tablet, through Oral route. Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-10 11:22:04, ended at 2014-05-10 11:42:38\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-10 11:55:00, ended at 2014-05-10 23:59:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- MCH [Entitic mass] by Automated count: 25.2 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 77.7 (femtoliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.9 (nanogram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 3.28 (milli-international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.95 (million per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Prothrombin time (PT): 13.5 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 326 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pre-surgery evaluation\n\n### Condition\n- Diverticulitis of colon\n- Gastroesophageal reflux disease\n- Joint pain of pelvic region\n- Restless legs\n- Congenital deformity of hip joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-05-24 00:00:00, ended at 2014-05-24 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2014-05-24, presumably until 2014-05-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-05-24 00:00:00, ended at 2014-05-24 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for open procedures involving hip joint; total hip arthroplasty\n\n### Condition\n- Degenerative joint disease of pelvis\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- cefazolin 1000 MG Injection, started on 2014-05-24, presumably until 2014-05-24\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- bupivacaine hydrochloride 7.5 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2014-05-24, presumably until 2014-05-24\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-05-24, presumably until 2014-05-24\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- ketamine 100 MG/ML Injectable Solution, started on 2014-05-24, presumably until 2014-05-24\n- 10 ML morphine sulfate 1 MG/ML Injection, started on 2014-05-24, presumably until 2014-05-24\n- 10 ML tranexamic acid 100 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- midazolam 1 MG/ML Injectable Solution, started on 2014-05-24, presumably until 2014-05-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-05-24 12:30:00, ended at 2014-05-27 13:10:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Body height: 5' 0\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.79 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.4 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n\n### Procedure\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Hip bearing surface, metal-on-polyethylene\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Physical therapy evaluation\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Radiologic examination, pelvis; 1 or 2 views\n- Total replacement of hip\n- Pre-surgery evaluation\n- Occupational therapy evaluation\n\n### Condition\n- Acute postoperative pain\n- Restless legs\n- Diverticulitis of colon\n- Primary diagnosis: Joint pain of pelvic region\n- Congenital deformity of hip joint\n- Gastroesophageal reflux disease\n\n### Drug\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2014-05-24, presumably until 2014-05-24\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-05-24, presumably until 2014-05-24\n- Streptococcus thermophilus, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2014-05-25, presumably until 2014-11-21, with intended 0 refill(s). Instructions: inject 0.4 mL subcutaneous (under the skin) daily.\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-25\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-05-24, presumably until 2014-11-21, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. Take while taking opioids. Hold for loose stools.\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2014-05-24, presumably until 2014-05-26\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2014-05-24, presumably until 2014-05-27\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2014-05-25, presumably until 2014-11-21, with intended 1 refill(s). Instructions: take 1 Packet by mouth daily. Take while on opioids. Hold for loose stool.\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-25\n- Lactobacillus delbrueckii subsp. bulgaricus, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2014-05-25, presumably until 2014-05-25\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2014-05-24, presumably until 2014-11-21, with intended 0 refill(s). Instructions: take 1-3 Tabs by mouth every 4 hours as needed for Pain.\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2014-05-25, presumably until 2014-05-25\n- Lactobacillus acidophilus, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- Bifidobacterium bifidum, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-06-12 00:00:00, ended at 2014-06-12 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Prosthetic arthroplasty of hip\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-11 11:49:00, ended at 2014-07-11 23:59:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, pelvis; 1 or 2 views\n- Radiologic examination, hip, unilateral; 1 view\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-11-21 10:32:16, ended at 2014-11-21 12:31:16\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-29 10:01:00, ended at 2015-05-29 23:59:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n- Radiologic examination, pelvis; 1 or 2 views\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Hyperlipidemia within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-02 10:22:59, ended at 2014-04-02 12:04:14\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- Radiologic examination, pelvis; 1 or 2 views\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of pelvis\n\n### Drug\n- naproxen sodium 220 MG Oral Tablet, through Oral route, presumably until 2014-05-10. Instructions: take  by mouth 2 times a day as needed.\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route. Instructions: take 20 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-04-02 10:23:00, ended at 2014-04-02 23:59:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, pelvis; 1 or 2 views\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n\n### Condition\n- Degenerative joint disease of pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-10 09:30:27, ended at 2014-05-10 11:18:23\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Pre-surgery evaluation\n\n### Condition\n- Diverticulitis of colon\n- Primary diagnosis: Joint pain of pelvic region\n- Congenital deformity of hip joint\n- Gastroesophageal reflux disease\n- Restless legs\n\n### Drug\n- naproxen sodium 220 MG Oral Tablet, through Oral route. Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-10 11:22:04, ended at 2014-05-10 11:42:38\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-10 11:55:00, ended at 2014-05-10 23:59:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- MCH [Entitic mass] by Automated count: 25.2 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 77.7 (femtoliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.9 (nanogram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 3.28 (milli-international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.95 (million per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Prothrombin time (PT): 13.5 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 326 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pre-surgery evaluation\n\n### Condition\n- Diverticulitis of colon\n- Gastroesophageal reflux disease\n- Joint pain of pelvic region\n- Restless legs\n- Congenital deformity of hip joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-05-24 00:00:00, ended at 2014-05-24 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2014-05-24, presumably until 2014-05-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-05-24 00:00:00, ended at 2014-05-24 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for open procedures involving hip joint; total hip arthroplasty\n\n### Condition\n- Degenerative joint disease of pelvis\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- cefazolin 1000 MG Injection, started on 2014-05-24, presumably until 2014-05-24\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- bupivacaine hydrochloride 7.5 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2014-05-24, presumably until 2014-05-24\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-05-24, presumably until 2014-05-24\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- ketamine 100 MG/ML Injectable Solution, started on 2014-05-24, presumably until 2014-05-24\n- 10 ML morphine sulfate 1 MG/ML Injection, started on 2014-05-24, presumably until 2014-05-24\n- 10 ML tranexamic acid 100 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- midazolam 1 MG/ML Injectable Solution, started on 2014-05-24, presumably until 2014-05-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-05-24 12:30:00, ended at 2014-05-27 13:10:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Body height: 5' 0\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.79 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.4 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n\n### Procedure\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Hip bearing surface, metal-on-polyethylene\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Physical therapy evaluation\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Radiologic examination, pelvis; 1 or 2 views\n- Total replacement of hip\n- Pre-surgery evaluation\n- Occupational therapy evaluation\n\n### Condition\n- Acute postoperative pain\n- Restless legs\n- Diverticulitis of colon\n- Primary diagnosis: Joint pain of pelvic region\n- Congenital deformity of hip joint\n- Gastroesophageal reflux disease\n\n### Drug\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2014-05-24, presumably until 2014-05-24\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-05-24, presumably until 2014-05-24\n- Streptococcus thermophilus, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2014-05-25, presumably until 2014-11-21, with intended 0 refill(s). Instructions: inject 0.4 mL subcutaneous (under the skin) daily.\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-25\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-05-24, presumably until 2014-11-21, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. Take while taking opioids. Hold for loose stools.\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2014-05-24, presumably until 2014-05-26\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2014-05-24, presumably until 2014-05-27\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2014-05-25, presumably until 2014-11-21, with intended 1 refill(s). Instructions: take 1 Packet by mouth daily. Take while on opioids. Hold for loose stool.\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-25\n- Lactobacillus delbrueckii subsp. bulgaricus, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2014-05-25, presumably until 2014-05-25\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2014-05-24, presumably until 2014-11-21, with intended 0 refill(s). Instructions: take 1-3 Tabs by mouth every 4 hours as needed for Pain.\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2014-05-25, presumably until 2014-05-25\n- Lactobacillus acidophilus, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n- Bifidobacterium bifidum, through Oral route, started on 2014-05-25, presumably until 2014-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-06-12 00:00:00, ended at 2014-06-12 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Prosthetic arthroplasty of hip\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-11 11:49:00, ended at 2014-07-11 23:59:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, pelvis; 1 or 2 views\n- Radiologic examination, hip, unilateral; 1 view\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-11-21 10:32:16, ended at 2014-11-21 12:31:16\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-29 10:01:00, ended at 2015-05-29 23:59:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n- Radiologic examination, pelvis; 1 or 2 views\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Hyperlipidemia within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of hyperlipidemia means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "3d3bacee159ce66419ffd8ed1625c63eea52252f6490890d91e394330c42c62a", "prompt_hash": "3a0517c76b86fb222025ef8856b2988308f00ad0efbc742abadb8e8e026dea69", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 4, "doc": {"person_id": 115967856, "visit_occurrence_id": 39958617, "death_date": "2020-06-30", "visit_concept_name": "Office Visit", "visit_start_datetime": "2010-06-29 12:56:24", "visit_end_datetime": "2010-06-29 14:41:45", "visit_length_in_hours": 1.7558333333333334, "integrated_visit_record": "## Visit\nThis visit record, was from Office Visit, started at 2010-06-29 12:56:24, ended at 2010-06-29 14:41:45\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Prosthetic arthroplasty of hip\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 83, "patient_first_visit_date": "2008-02-17 00:00:00", "patient_last_visit_date": "2018-10-23 10:43:00", "end_obs_date": "2011-06-29", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 18, "cumulated_visit_num": 18, "cumulated_approximate_token_count": 6821, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2008-02-17 00:00:00, ended at 2008-02-17 00:00:00\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.19 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.67 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-10 00:00:00, ended at 2008-03-10 00:00:00\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 298 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 32 (millimeter per hour)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 4.62 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.82 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.75 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-24 00:00:00, ended at 2008-03-24 00:00:00\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.60 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 45 (milliliter per minute per square meter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.39 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 350 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.30 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Prothrombin time (PT): 13.5 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 37 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-09-22 11:30:15, ended at 2009-09-22 13:22:26\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-22 12:07:00, ended at 2009-09-22 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hips, bilateral, minimum of 2 views of each hip, including anteroposterior view of pelvis\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-09-23 15:01:05, ended at 2009-09-23 15:48:43\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Osteoarthritis\n- Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-23 15:57:00, ended at 2009-09-23 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.4 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 144 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.78 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 328 (thousand per microliter)\n- Prothrombin time (PT): 13.1 (second)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.5 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary cardiomyopathy\n- Osteoarthritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-19 14:30:00, ended at 2009-10-19 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-11-19 00:00:00, ended at 2009-11-19 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Joint derangement\n- Primary diagnosis: Disorder of hip joint\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2009-11-19, presumably until 2010-05-18, with quantity of 8.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-06 12:42:36, ended at 2009-12-06 13:53:39\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mechanical complication of internal orthopedic device, implant AND/OR graft\n- Primary diagnosis: Disorder of hip joint\n- Primary diagnosis: Joint derangement\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-03-16 13:06:25, ended at 2010-03-16 15:37:46\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Prosthetic arthroplasty of hip\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-16 14:16:00, ended at 2010-03-16 16:16:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, pelvis; complete, minimum of 3 views\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n\n### Condition\n- Aseptic necrosis of bone\n- Mechanical complication of internal joint prosthesis\n- Congenital subluxation of hip\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-03-20 00:00:00, ended at 2010-03-20 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of hip joint\n- Primary diagnosis: Joint derangement\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2010-03-20, presumably until 2010-09-16. Instructions: take 1 Tab by mouth every 6 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-05-02 11:55:20, ended at 2010-05-02 14:14:25\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Pre-surgery evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-02 14:21:00, ended at 2010-05-02 23:59:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.28 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.81 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 139 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Calcium [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.3 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Prothrombin time (PT): 12.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Joint derangement\n- Disorder of hip joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-05-15 12:48:00, ended at 2010-05-18 09:50:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.09 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.73 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 175 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 113 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.81 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.40 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.19 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Bone graft\n- Occupational therapy evaluation\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Revision of total hip replacement\n- Radiologic examination, pelvis; 1 or 2 views\n- Physical therapy evaluation\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n\n### Condition\n- Chronic hepatitis C\n- Mitral valve disorder\n- Primary cardiomyopathy\n- Asthma\n- Essential hypertension\n- Joint derangement\n- Periprosthetic osteolysis\n- Prosthetic joint dislocation\n- Prosthetic joint loosening\n- Disorder of hip joint\n- Bone marrow transplant present\n\n### Drug\n- polysaccharide iron complex, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous gluconate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous fumarate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous ascorbate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- iron,peptonized, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous succinate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous bisglycinate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous cysteine glycinate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous aspartate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ammonium ferrous sulfate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- soy protein-iron complex, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2010-05-15, presumably until 2010-05-15\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2010-05-17, presumably until 2010-05-17\n- ferrous carbonate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-05-17\n- ferrous glycine sulfate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- folic acid, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2010-05-17, presumably until 2013-06-11, with quantity of 11.0, with intended 0 refill(s). Instructions: 40 mg by SUBCUTANEOUS route daily. \n- 12 HR oxycodone hydrochloride 20 MG Extended Release Oral Tablet, through Oral route, started on 2010-05-15, presumably until 2010-05-16\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2010-05-15, presumably until 2010-05-16\n- iron succinyl milk protein complex, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- iron-dextran complex, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- teferrol, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-05-16\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2010-05-16, presumably until 2011-05-17, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n- ferrous asparto glycinate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous cacodylate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-05-15, presumably until 2010-05-16\n- iron, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous oxalate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2010-05-17, presumably until 2010-05-17\n- iron sucrose, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous sulfate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- iron carbonyl, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous lactate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous chloride, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-05-16\n- 0.3 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2010-05-16, presumably until 2010-05-18\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-11-13, with quantity of 90.0, with intended 0 refill(s). Instructions: take 2-4 Tabs by mouth every 4 hours as needed \n- iron sorbitex, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous phosphate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- carvedilol 12.5 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2013-06-11. Instructions: take by mouth 2 times a day. \n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-05-15, presumably until 2010-05-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-05-30 15:08:36, ended at 2010-05-30 16:33:38\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of hip joint\n- Primary diagnosis: Joint derangement\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-06-29 12:56:24, ended at 2010-06-29 14:41:45\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Prosthetic arthroplasty of hip\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Hyperlipidemia within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-02-17 00:00:00, ended at 2008-02-17 00:00:00\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.19 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.67 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-10 00:00:00, ended at 2008-03-10 00:00:00\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 298 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 32 (millimeter per hour)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 4.62 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.82 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.75 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-24 00:00:00, ended at 2008-03-24 00:00:00\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.60 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 45 (milliliter per minute per square meter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.39 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 350 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.30 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Prothrombin time (PT): 13.5 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 37 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-09-22 11:30:15, ended at 2009-09-22 13:22:26\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-22 12:07:00, ended at 2009-09-22 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hips, bilateral, minimum of 2 views of each hip, including anteroposterior view of pelvis\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-09-23 15:01:05, ended at 2009-09-23 15:48:43\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Osteoarthritis\n- Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-23 15:57:00, ended at 2009-09-23 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.4 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 144 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.78 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 328 (thousand per microliter)\n- Prothrombin time (PT): 13.1 (second)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.5 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary cardiomyopathy\n- Osteoarthritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-19 14:30:00, ended at 2009-10-19 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-11-19 00:00:00, ended at 2009-11-19 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Joint derangement\n- Primary diagnosis: Disorder of hip joint\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2009-11-19, presumably until 2010-05-18, with quantity of 8.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-06 12:42:36, ended at 2009-12-06 13:53:39\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mechanical complication of internal orthopedic device, implant AND/OR graft\n- Primary diagnosis: Disorder of hip joint\n- Primary diagnosis: Joint derangement\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-03-16 13:06:25, ended at 2010-03-16 15:37:46\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Prosthetic arthroplasty of hip\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-16 14:16:00, ended at 2010-03-16 16:16:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, pelvis; complete, minimum of 3 views\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n\n### Condition\n- Aseptic necrosis of bone\n- Mechanical complication of internal joint prosthesis\n- Congenital subluxation of hip\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-03-20 00:00:00, ended at 2010-03-20 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of hip joint\n- Primary diagnosis: Joint derangement\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2010-03-20, presumably until 2010-09-16. Instructions: take 1 Tab by mouth every 6 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-05-02 11:55:20, ended at 2010-05-02 14:14:25\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Pre-surgery evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-02 14:21:00, ended at 2010-05-02 23:59:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.28 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.81 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 139 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Calcium [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.3 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Prothrombin time (PT): 12.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Joint derangement\n- Disorder of hip joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-05-15 12:48:00, ended at 2010-05-18 09:50:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.09 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.73 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 175 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 113 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.81 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.40 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.19 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Bone graft\n- Occupational therapy evaluation\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Revision of total hip replacement\n- Radiologic examination, pelvis; 1 or 2 views\n- Physical therapy evaluation\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n\n### Condition\n- Chronic hepatitis C\n- Mitral valve disorder\n- Primary cardiomyopathy\n- Asthma\n- Essential hypertension\n- Joint derangement\n- Periprosthetic osteolysis\n- Prosthetic joint dislocation\n- Prosthetic joint loosening\n- Disorder of hip joint\n- Bone marrow transplant present\n\n### Drug\n- polysaccharide iron complex, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous gluconate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous fumarate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous ascorbate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- iron,peptonized, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous succinate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous bisglycinate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous cysteine glycinate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous aspartate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ammonium ferrous sulfate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- soy protein-iron complex, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2010-05-15, presumably until 2010-05-15\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2010-05-17, presumably until 2010-05-17\n- ferrous carbonate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-05-17\n- ferrous glycine sulfate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- folic acid, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2010-05-17, presumably until 2013-06-11, with quantity of 11.0, with intended 0 refill(s). Instructions: 40 mg by SUBCUTANEOUS route daily. \n- 12 HR oxycodone hydrochloride 20 MG Extended Release Oral Tablet, through Oral route, started on 2010-05-15, presumably until 2010-05-16\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2010-05-15, presumably until 2010-05-16\n- iron succinyl milk protein complex, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- iron-dextran complex, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- teferrol, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-05-16\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2010-05-16, presumably until 2011-05-17, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n- ferrous asparto glycinate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous cacodylate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-05-15, presumably until 2010-05-16\n- iron, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous oxalate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2010-05-17, presumably until 2010-05-17\n- iron sucrose, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous sulfate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- iron carbonyl, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous lactate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous chloride, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-05-16\n- 0.3 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2010-05-16, presumably until 2010-05-18\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-11-13, with quantity of 90.0, with intended 0 refill(s). Instructions: take 2-4 Tabs by mouth every 4 hours as needed \n- iron sorbitex, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous phosphate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- carvedilol 12.5 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2013-06-11. Instructions: take by mouth 2 times a day. \n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-05-15, presumably until 2010-05-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-05-30 15:08:36, ended at 2010-05-30 16:33:38\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of hip joint\n- Primary diagnosis: Joint derangement\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-06-29 12:56:24, ended at 2010-06-29 14:41:45\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Prosthetic arthroplasty of hip\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Hyperlipidemia within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of hyperlipidemia means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "095fe041e500853f219d348b65c98524582f08082258c7c0c31568cc8cd4998c", "prompt_hash": "a881741e657be871de428851c0e667079e1499624fd083864bad104c661297b5", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 5, "doc": {"person_id": 115967988, "visit_occurrence_id": 68382974, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2015-01-09 08:30:00", "visit_end_datetime": "2015-01-09 23:59:00", "visit_length_in_hours": 15.483333333333333, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-09 08:30:00, ended at 2015-01-09 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 93, "patient_first_visit_date": "2013-10-15 08:07:00", "patient_last_visit_date": "2016-08-15 13:04:00", "end_obs_date": "2016-01-09", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "recurrent", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 33, "cumulated_visit_num": 33, "cumulated_approximate_token_count": 7035, "visit_cumulated": "## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-15 08:07:00, ended at 2013-10-15 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3.386\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-10-16 00:00:00, ended at 2013-10-16 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-25 07:38:00, ended at 2013-10-25 13:50:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Closed [percutaneous] [needle] biopsy of intra-abdominal mass\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Collection of venous blood by venipuncture\n- CT of abdomen\n- Computed tomography guidance for needle placement (eg, biopsy, aspiration, injection, localization device), radiological supervision and interpretation\n- Biopsy, abdominal or retroperitoneal mass, percutaneous needle\n\n### Condition\n- Intra-abdominal and pelvic swelling, mass and lump\n- Neoplasm of uncertain behavior of soft tissues\n- Neoplastic disease of uncertain behavior\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-10-25, presumably until 2013-10-25\n- midazolam 1 MG/ML Injectable Solution, started on 2013-10-25, presumably until 2013-10-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-11-06 00:00:00, ended at 2013-11-06 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-11 00:00:00, ended at 2013-11-11 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-11 00:00:00, ended at 2013-11-11 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-15 10:38:00, ended at 2013-11-15 12:47:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- Intra-abdominal and pelvic swelling, mass and lump\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-15 12:48:00, ended at 2013-11-15 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2013-11-27 00:00:00, ended at 2013-11-27 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2013-11-27, presumably until 2013-11-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-11-27 00:00:00, ended at 2013-11-27 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for extraperitoneal procedures in lower abdomen, including urinary tract; adrenalectomy\n\n### Condition\n- Disorder of peritoneum\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2013-11-27, presumably until 2013-11-27\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2013-11-27, presumably until 2013-11-27\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2013-11-27, presumably until 2013-11-27\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2013-11-27, presumably until 2013-11-27\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2013-11-27, presumably until 2013-11-27\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-11-27, presumably until 2013-11-27\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-11-27, presumably until 2013-11-27\n- 250 ML lidocaine hydrochloride 8 MG/ML Injection, through Intravenous route, started on 2013-11-27, presumably until 2013-11-27\n- midazolam 1 MG/ML Injectable Solution, started on 2013-11-27, presumably until 2013-11-27\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2013-11-27, presumably until 2013-11-27\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2013-11-27, presumably until 2013-11-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-11-27 11:28:00, ended at 2013-12-04 17:01:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.1 (percent)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 0.85 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 126 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.7 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Body height: 5' 4\" (inch (US))\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.2 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Prothrombin time (PT): 14.6 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCH [Entitic mass] by Automated count: 29.1 (picogram)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.35 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n\n### Procedure\n- Physical therapy evaluation\n- Collection of venous blood by venipuncture\n- Excision or destruction of peritoneal tissue\n- Total splenectomy\n- Other partial pancreatectomy\n- Nephroureterectomy\n- Radiologic examination, chest; single view, frontal\n- Unilateral adrenalectomy\n\n### Condition\n- Headache\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n- Primary malignant neoplasm of retroperitoneum\n- Obesity\n\n### Drug\n- sodium phosphate, dibasic 59.3 MG/ML / sodium phosphate, monobasic 161 MG/ML Enema, through Rectal route, started on 2013-12-04, presumably until 2013-12-04\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-12-01, presumably until 2013-12-02\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2013-11-28, presumably until 2013-12-04\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2013-11-28, presumably until 2013-12-04\n- sennosides, USP 8.6 MG Oral Capsule, through Oral route, started on 2013-12-04, presumably until 2014-04-18, with intended 0 refill(s). Instructions: take 1-2 Caps by mouth every bedtime.\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2013-11-28, presumably until 2013-12-01\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2013-12-02, presumably until 2014-04-18, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily as needed.\n- 8 HR acetaminophen 650 MG Extended Release Oral Tablet, through Oral route, started on 2013-12-04, presumably until 2014-08-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 to 6 hours as needed.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-11-27, presumably until 2013-12-02\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-11-27, presumably until 2013-11-30\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-11-28, presumably until 2014-04-18, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain.\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2013-11-28, presumably until 2013-11-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-12-06 00:00:00, ended at 2013-12-06 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- 0.5 ML Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumo..., through Intramuscular route, started on 2013-12-06, presumably until 2014-04-18, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n- 0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection, through Intramuscular route, started on 2013-12-06, presumably until 2013-12-07, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2013-12-06 15:55:00, ended at 2013-12-06 20:41:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.5 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 123 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.15 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.30 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 189 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Hematocrit [Volume Fraction] of Blood: 44 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 15.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.6 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 518 (thousand per microliter)\n- Potassium [Moles/volume] in Blood: 3.8 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Blood: 1.13 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.36 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.77 (thousand per microliter)\n- Base excess in Blood by calculation: 5.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Sodium [Moles/volume] in Blood: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.7 (femtoliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Ascites\n- Primary malignant neoplasm of retroperitoneum\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n- Postprocedural state finding\n- Primary malignant neoplasm of soft tissues\n- Abdominal pain\n\n### Drug\n- ibuprofen 200 MG Oral Tablet, through Oral route, presumably until 2014-08-27. Instructions: take 200-400 mg by mouth daily as needed.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-12-06, presumably until 2013-12-06\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2013-12-06, presumably until 2013-12-06\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, presumably until 2014-01-17. Instructions: take 20 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-09 00:00:00, ended at 2013-12-09 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2013-12-09, presumably until 2014-04-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-10 14:48:00, ended at 2013-12-10 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-17 08:44:00, ended at 2014-01-17 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-20 00:00:00, ended at 2014-01-20 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-17 00:00:00, ended at 2014-04-17 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-17 00:00:00, ended at 2014-04-17 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-18 09:52:00, ended at 2014-04-18 12:30:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n- Incisional hernia\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-18 12:31:00, ended at 2014-04-18 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.37\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n- Incisional hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-04 00:00:00, ended at 2014-05-04 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-25 10:14:00, ended at 2014-07-25 12:21:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-25 12:22:00, ended at 2014-07-25 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-27 00:00:00, ended at 2014-07-27 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-29 00:00:00, ended at 2014-07-29 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-08-13 10:23:59, ended at 2014-08-13 13:46:40\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.992\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of body wall\n- Incisional hernia\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- omeprazole 10 MG Delayed Release Oral Capsule, through Oral route, presumably until 2016-03-03, with intended 0 refill(s). Instructions: take  by mouth daily.\n- lisinopril 10 MG Oral Tablet, started on 2014-06-12, presumably until 2015-12-29, with intended 0 refill(s). Instructions: daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-08-28 00:00:00, ended at 2014-08-28 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2014-08-28, presumably until 2014-08-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-28 00:00:00, ended at 2014-08-28 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for hernia repairs in upper abdomen; lumbar and ventral (incisional) hernias and/or wound dehiscence\n\n### Condition\n- Incisional hernia\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2014-08-28, presumably until 2014-08-28\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2014-08-28, presumably until 2014-08-28\n- cefazolin 1000 MG Injection, started on 2014-08-28, presumably until 2014-08-28\n- remifentanil 2 MG Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2014-08-28, presumably until 2014-08-28\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-08-28, presumably until 2014-08-28\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- 72 HR scopolamine 0.0139 MG/HR Transdermal System, through Transdermal route, started on 2014-08-28, presumably until 2014-08-28\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2014-08-28, presumably until 2014-08-28\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2014-08-28, presumably until 2014-08-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-08-28 05:03:00, ended at 2014-08-29 18:40:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 266 (thousand per microliter)\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Laparoscopic incisional hernia repair with graft or prosthesis\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acquired absence of organ\n- Acute postoperative pain\n- Morbid obesity\n- Spasm\n- Incisional hernia\n- Primary diagnosis: Postprocedural state finding\n- Essential hypertension\n- Hernia of anterior abdominal wall\n- Abdominal pain\n- Gastroesophageal reflux disease\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-29\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-29\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-08-28, presumably until 2015-08-29, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2014-08-28, presumably until 2014-08-29\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-08-29, presumably until 2014-08-29\n- 2 ML diazepam 5 MG/ML Auto-Injector, started on 2014-08-29, presumably until 2014-08-29\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2014-08-28, presumably until 2014-08-29\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2014-08-29, presumably until 2015-02-25, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed.\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2014-08-28, presumably until 2014-08-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-10 14:07:36, ended at 2014-09-10 16:41:08\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-09 00:00:00, ended at 2015-01-09 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-09 08:30:00, ended at 2015-01-09 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Hyperlipidemia within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-15 08:07:00, ended at 2013-10-15 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3.386\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-10-16 00:00:00, ended at 2013-10-16 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-25 07:38:00, ended at 2013-10-25 13:50:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Closed [percutaneous] [needle] biopsy of intra-abdominal mass\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Collection of venous blood by venipuncture\n- CT of abdomen\n- Computed tomography guidance for needle placement (eg, biopsy, aspiration, injection, localization device), radiological supervision and interpretation\n- Biopsy, abdominal or retroperitoneal mass, percutaneous needle\n\n### Condition\n- Intra-abdominal and pelvic swelling, mass and lump\n- Neoplasm of uncertain behavior of soft tissues\n- Neoplastic disease of uncertain behavior\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-10-25, presumably until 2013-10-25\n- midazolam 1 MG/ML Injectable Solution, started on 2013-10-25, presumably until 2013-10-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-11-06 00:00:00, ended at 2013-11-06 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-11 00:00:00, ended at 2013-11-11 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-11 00:00:00, ended at 2013-11-11 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-15 10:38:00, ended at 2013-11-15 12:47:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- Intra-abdominal and pelvic swelling, mass and lump\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-15 12:48:00, ended at 2013-11-15 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2013-11-27 00:00:00, ended at 2013-11-27 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2013-11-27, presumably until 2013-11-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-11-27 00:00:00, ended at 2013-11-27 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for extraperitoneal procedures in lower abdomen, including urinary tract; adrenalectomy\n\n### Condition\n- Disorder of peritoneum\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2013-11-27, presumably until 2013-11-27\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2013-11-27, presumably until 2013-11-27\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2013-11-27, presumably until 2013-11-27\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2013-11-27, presumably until 2013-11-27\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2013-11-27, presumably until 2013-11-27\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-11-27, presumably until 2013-11-27\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-11-27, presumably until 2013-11-27\n- 250 ML lidocaine hydrochloride 8 MG/ML Injection, through Intravenous route, started on 2013-11-27, presumably until 2013-11-27\n- midazolam 1 MG/ML Injectable Solution, started on 2013-11-27, presumably until 2013-11-27\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2013-11-27, presumably until 2013-11-27\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2013-11-27, presumably until 2013-11-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-11-27 11:28:00, ended at 2013-12-04 17:01:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.1 (percent)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 0.85 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 126 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.7 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Body height: 5' 4\" (inch (US))\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.2 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Prothrombin time (PT): 14.6 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCH [Entitic mass] by Automated count: 29.1 (picogram)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.35 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n\n### Procedure\n- Physical therapy evaluation\n- Collection of venous blood by venipuncture\n- Excision or destruction of peritoneal tissue\n- Total splenectomy\n- Other partial pancreatectomy\n- Nephroureterectomy\n- Radiologic examination, chest; single view, frontal\n- Unilateral adrenalectomy\n\n### Condition\n- Headache\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n- Primary malignant neoplasm of retroperitoneum\n- Obesity\n\n### Drug\n- sodium phosphate, dibasic 59.3 MG/ML / sodium phosphate, monobasic 161 MG/ML Enema, through Rectal route, started on 2013-12-04, presumably until 2013-12-04\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-12-01, presumably until 2013-12-02\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2013-11-28, presumably until 2013-12-04\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2013-11-28, presumably until 2013-12-04\n- sennosides, USP 8.6 MG Oral Capsule, through Oral route, started on 2013-12-04, presumably until 2014-04-18, with intended 0 refill(s). Instructions: take 1-2 Caps by mouth every bedtime.\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2013-11-28, presumably until 2013-12-01\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2013-12-02, presumably until 2014-04-18, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily as needed.\n- 8 HR acetaminophen 650 MG Extended Release Oral Tablet, through Oral route, started on 2013-12-04, presumably until 2014-08-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 to 6 hours as needed.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-11-27, presumably until 2013-12-02\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-11-27, presumably until 2013-11-30\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-11-28, presumably until 2014-04-18, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain.\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2013-11-28, presumably until 2013-11-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-12-06 00:00:00, ended at 2013-12-06 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- 0.5 ML Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumo..., through Intramuscular route, started on 2013-12-06, presumably until 2014-04-18, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n- 0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection, through Intramuscular route, started on 2013-12-06, presumably until 2013-12-07, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2013-12-06 15:55:00, ended at 2013-12-06 20:41:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.5 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 123 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.15 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.30 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 189 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Hematocrit [Volume Fraction] of Blood: 44 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 15.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.6 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 518 (thousand per microliter)\n- Potassium [Moles/volume] in Blood: 3.8 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Blood: 1.13 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.36 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.77 (thousand per microliter)\n- Base excess in Blood by calculation: 5.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Sodium [Moles/volume] in Blood: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.7 (femtoliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Ascites\n- Primary malignant neoplasm of retroperitoneum\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n- Postprocedural state finding\n- Primary malignant neoplasm of soft tissues\n- Abdominal pain\n\n### Drug\n- ibuprofen 200 MG Oral Tablet, through Oral route, presumably until 2014-08-27. Instructions: take 200-400 mg by mouth daily as needed.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-12-06, presumably until 2013-12-06\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2013-12-06, presumably until 2013-12-06\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, presumably until 2014-01-17. Instructions: take 20 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-09 00:00:00, ended at 2013-12-09 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2013-12-09, presumably until 2014-04-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-10 14:48:00, ended at 2013-12-10 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-17 08:44:00, ended at 2014-01-17 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-20 00:00:00, ended at 2014-01-20 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-17 00:00:00, ended at 2014-04-17 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-17 00:00:00, ended at 2014-04-17 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-18 09:52:00, ended at 2014-04-18 12:30:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n- Incisional hernia\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-18 12:31:00, ended at 2014-04-18 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.37\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n- Incisional hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-04 00:00:00, ended at 2014-05-04 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-25 10:14:00, ended at 2014-07-25 12:21:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-25 12:22:00, ended at 2014-07-25 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-27 00:00:00, ended at 2014-07-27 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-29 00:00:00, ended at 2014-07-29 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-08-13 10:23:59, ended at 2014-08-13 13:46:40\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.992\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of body wall\n- Incisional hernia\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- omeprazole 10 MG Delayed Release Oral Capsule, through Oral route, presumably until 2016-03-03, with intended 0 refill(s). Instructions: take  by mouth daily.\n- lisinopril 10 MG Oral Tablet, started on 2014-06-12, presumably until 2015-12-29, with intended 0 refill(s). Instructions: daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-08-28 00:00:00, ended at 2014-08-28 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2014-08-28, presumably until 2014-08-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-28 00:00:00, ended at 2014-08-28 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for hernia repairs in upper abdomen; lumbar and ventral (incisional) hernias and/or wound dehiscence\n\n### Condition\n- Incisional hernia\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2014-08-28, presumably until 2014-08-28\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2014-08-28, presumably until 2014-08-28\n- cefazolin 1000 MG Injection, started on 2014-08-28, presumably until 2014-08-28\n- remifentanil 2 MG Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2014-08-28, presumably until 2014-08-28\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-08-28, presumably until 2014-08-28\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- 72 HR scopolamine 0.0139 MG/HR Transdermal System, through Transdermal route, started on 2014-08-28, presumably until 2014-08-28\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2014-08-28, presumably until 2014-08-28\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2014-08-28, presumably until 2014-08-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-08-28 05:03:00, ended at 2014-08-29 18:40:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 266 (thousand per microliter)\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Laparoscopic incisional hernia repair with graft or prosthesis\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acquired absence of organ\n- Acute postoperative pain\n- Morbid obesity\n- Spasm\n- Incisional hernia\n- Primary diagnosis: Postprocedural state finding\n- Essential hypertension\n- Hernia of anterior abdominal wall\n- Abdominal pain\n- Gastroesophageal reflux disease\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-29\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-29\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-08-28, presumably until 2015-08-29, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2014-08-28, presumably until 2014-08-29\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-08-29, presumably until 2014-08-29\n- 2 ML diazepam 5 MG/ML Auto-Injector, started on 2014-08-29, presumably until 2014-08-29\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2014-08-28, presumably until 2014-08-29\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2014-08-29, presumably until 2015-02-25, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed.\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2014-08-28, presumably until 2014-08-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-10 14:07:36, ended at 2014-09-10 16:41:08\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-09 00:00:00, ended at 2015-01-09 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-09 08:30:00, ended at 2015-01-09 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Hyperlipidemia within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of hyperlipidemia means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "e2d5239cb3a08a651b0636502e6d6c8f7b26964641dcdfd990575ccdf9f4654c", "prompt_hash": "41f2c7d589c7d1bd3c0b561ed6869b30bebbd4364de1f525d97d27a0f0f1a047", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 6, "doc": {"person_id": 115968035, "visit_occurrence_id": 174248134, "death_date": null, "visit_concept_name": "Telehealth", "visit_start_datetime": "2021-02-07 00:00:00", "visit_end_datetime": "2021-02-07 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Telehealth, started at 2021-02-07 00:00:00, ended at 2021-02-07 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sciatica\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 82, "patient_first_visit_date": "2012-02-25 00:00:00", "patient_last_visit_date": "2023-01-06 00:00:00", "end_obs_date": "2022-02-07", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 1, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 69, "cumulated_visit_num": 69, "cumulated_approximate_token_count": 11418, "visit_cumulated": "## Visit\nThis visit record, was from Pharmacy visit, started at 2012-02-25 00:00:00, ended at 2012-02-25 00:00:00\nThe patient in this visit was 36 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 25 MG Oral Tablet, through Oral route, started on 2012-02-25, presumably until 2019-05-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-02-26 00:00:00, ended at 2012-02-26 00:00:00\nThe patient in this visit was 36 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR bupropion hydrochloride 300 MG Extended Release Oral Tablet, started on 2012-02-26, presumably until 2013-02-07, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-01-16 00:00:00, ended at 2013-01-16 00:00:00\nThe patient in this visit was 37 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 113 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 197 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.73 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.2 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 82 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 0.779 (micro-international unit per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 27 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.5 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 57 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Primary cardiomyopathy\n- Primary diagnosis: Non-toxic multinodular goiter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-07 14:01:58, ended at 2013-02-07 14:47:43\nThe patient in this visit was 37 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n- General examination of patient\n\n### Condition\n- Attention deficit hyperactivity disorder, predominantly inattentive type\n- Non-toxic multinodular goiter\n- Chronic nonalcoholic liver disease\n- Sleep apnea\n- Bipolar disorder\n- Primary cardiomyopathy\n\n### Drug\n- lurasidone hydrochloride 40 MG Oral Tablet, through Oral route, presumably until 2014-06-21. Instructions: take  by mouth. Split in 1/4 daily\n- lurasidone hydrochloride 20 MG Oral Tablet, through Oral route, presumably until 2014-06-21. Instructions: take  by mouth. Split in 1/4 daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-21 16:51:40, ended at 2014-06-21 17:20:47\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic nonalcoholic liver disease\n- Primary diagnosis: Non-toxic multinodular goiter\n- Bipolar disorder\n- Primary cardiomyopathy\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2014-06-21, presumably until 2015-08-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-10-04 00:00:00, ended at 2014-10-04 00:00:00\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2014-10-04, presumably until 2015-10-25, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-04-17 14:39:32, ended at 2015-04-17 15:09:27\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (international unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.2 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 83 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.9 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.5 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 0.679 (micro-international unit per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.8 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 27.9 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Body height: 5' 1\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-toxic multinodular goiter\n- Chronic nonalcoholic liver disease\n- Primary cardiomyopathy\n- Primary diagnosis: Dysfunction of eustachian tube\n\n### Drug\n- ethacrynic acid 25 MG Oral Tablet, through Oral route, presumably until 2015-10-25, with intended 0 refill(s). Instructions: take 2 Tabs by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-04-19 00:00:00, ended at 2015-04-19 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-05-01 00:00:00, ended at 2015-05-01 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2015-05-01, presumably until 2016-05-01, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-01 13:57:32, ended at 2015-05-01 14:38:58\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Non-toxic multinodular goiter\n- Bipolar disorder\n- Sleep apnea\n- Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-05 00:00:00, ended at 2015-08-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-toxic multinodular goiter\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2015-08-05, presumably until 2015-09-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-30 00:00:00, ended at 2015-08-30 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-toxic multinodular goiter\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2015-09-02, presumably until 2016-05-01, with intended 6 refill(s). Instructions: take 1 Tab by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-25 00:00:00, ended at 2015-10-25 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2015-10-25, presumably until 2017-04-09, with intended 6 refill(s). Instructions: Use as directed\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2015-10-25, presumably until 2017-04-09, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-25 10:07:18, ended at 2015-10-25 11:09:46\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Attention deficit hyperactivity disorder\n- Posttraumatic stress disorder\n\n### Drug\n- triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2019-05-10, with intended 0 refill(s). Instructions: 55 mcg by Nasal route daily\n- bumetanide 0.5 MG Oral Tablet, started on 2015-10-25, presumably until 2017-07-20, with intended 3 refill(s). Instructions: Take 1 po daily prn swelling\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (81 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-27 13:41:10, ended at 2016-02-27 14:07:45\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-18 00:00:00, ended at 2016-03-18 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-24 09:59:32, ended at 2016-03-24 11:15:21\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-14 09:42:59, ended at 2016-04-14 10:14:56\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-05-01 00:00:00, ended at 2016-05-01 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2016-05-01, presumably until 2016-12-16, with intended 6 refill(s). Instructions: take 1 Tab by mouth Every Day\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2016-05-01, presumably until 2016-05-08, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-07 00:00:00, ended at 2016-05-07 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Biceps tendinitis\n- Shoulder joint pain\n- Nontraumatic rotator cuff tear\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-13 09:29:30, ended at 2016-05-13 10:06:48\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cardiomyopathy\n- Primary diagnosis: Acute bronchitis\n- Non-toxic multinodular goiter\n- Sleep apnea\n\n### Drug\n- 14 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2016-05-13, presumably until 2017-05-13, with intended 3 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-07-10 00:00:00, ended at 2016-07-10 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anesthesia of skin\n- Primary diagnosis: Low back pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-13 10:27:49, ended at 2016-11-13 11:24:59\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-toxic multinodular goiter\n- Primary diagnosis: Cardiomyopathy\n- Attention deficit hyperactivity disorder\n- Mixed bipolar I disorder in full remission\n- Mild intermittent asthma\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2016-11-13, presumably until 2017-11-13, with intended 3 refill(s). Instructions: apply 1 Patch to skin daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-16 00:00:00, ended at 2016-12-16 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2016-12-16, presumably until 2018-04-21, with intended 11 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-09 00:00:00, ended at 2017-04-09 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-04-09, presumably until 2018-07-26, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-09 00:00:00, ended at 2017-04-09 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2017-04-09, presumably until 2017-12-07, with intended 6 refill(s). Instructions: Use as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-30 10:51:26, ended at 2017-04-30 11:28:27\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Attention deficit hyperactivity disorder\n- Non-toxic multinodular goiter\n- Sleep apnea\n- Impaired glucose tolerance\n- Mixed bipolar I disorder in full remission\n- Primary diagnosis: Cardiomyopathy\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-07-02 00:00:00, ended at 2017-07-02 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-toxic uninodular goiter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-20 00:00:00, ended at 2017-07-20 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bumetanide 0.5 MG Oral Tablet, started on 2017-07-21, presumably until 2019-04-07, with intended 3 refill(s). Instructions: Take one tablet by mouth daily as needed for swelling.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-27 00:00:00, ended at 2017-07-27 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-07-28, presumably until 2017-08-04, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-09-22 00:00:00, ended at 2017-09-22 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- No conditions.\n\n### Drug\n- 1 ML hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe, through Intramuscular route, started on 2017-09-23, presumably until 2017-09-24, with intended 0 refill(s). Instructions: inject 1 mL into a muscle One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-09-24 00:00:00, ended at 2017-09-24 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-08 13:54:03, ended at 2017-10-08 13:54:21\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-10-26 00:00:00, ended at 2017-10-26 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.5 ML typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe, started on 2017-10-26, presumably until 2018-04-21, with intended 0 refill(s). Instructions: Injection 0.5 mL into the muscle One Time\n- 0.5 ML Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML Prefilled Syringe, through Intramuscular route, started on 2017-10-26, presumably until 2017-10-27, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle as directed\n- atovaquone 250 MG / proguanil hydrochloride 100 MG Oral Tablet, started on 2017-10-26, presumably until 2018-04-21, with intended 0 refill(s). Instructions: Take 1 tab po starting 1-2 days before trip,continue till one week after returning from trip\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-11-04 00:00:00, ended at 2017-11-04 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2017-11-04, presumably until 2018-04-21, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-07 00:00:00, ended at 2017-12-07 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2017-12-08, presumably until 2019-06-06, with intended 6 refill(s). Instructions: Use as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-12-13 00:00:00, ended at 2017-12-13 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sleep apnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-21 14:13:18, ended at 2018-04-21 14:51:16\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sleep apnea\n- Cardiomyopathy\n- Primary diagnosis: Acute maxillary sinusitis\n- Bipolar disorder in remission\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2018-04-21, presumably until 2019-06-06, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 4 to 6 hours as needed\n- ergocalciferol 1.25 MG Oral Capsule, through Oral route, started on 2018-04-21, presumably until 2020-01-25, with intended 3 refill(s). Instructions: take 1 Cap by mouth every 7 days\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2018-04-21, presumably until 2018-05-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n- valacyclovir 500 MG Oral Tablet, through Oral route, presumably until 2018-08-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day For 1 month during breakout\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-26 00:00:00, ended at 2018-07-26 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mild intermittent asthma\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2018-07-27, presumably until 2019-10-12, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-08-22 00:00:00, ended at 2018-08-22 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2018-08-22, presumably until 2019-03-25, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 30 days For 1 month during breakout\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-18 00:00:00, ended at 2018-10-18 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2018-10-18, presumably until 2019-07-25, with intended 3 refill(s). Instructions: USE IN EACH NOSTRIL AS DIRECTED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-03-14 00:00:00, ended at 2019-03-14 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney stone\n- Sleep apnea\n- Steatosis of liver\n- Uncomplicated asthma\n- Primary diagnosis: Urticaria due to cold and heat\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-25 00:00:00, ended at 2019-03-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ophthalmic herpes simplex\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2019-03-28, presumably until 2019-04-27, with intended 2 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 2 TIMES A DAY FOR 1 MONTH DURING BREAKOUT\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-07 00:00:00, ended at 2019-04-07 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cardiomyopathy\n\n### Drug\n- bumetanide 0.5 MG Oral Tablet, started on 2019-04-07, presumably until 2020-06-14, with intended 3 refill(s). Instructions: Take one tablet by mouth daily as needed for swelling.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-10 10:43:15, ended at 2019-05-10 14:22:35\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Sleep apnea\n- Cardiomyopathy\n\n### Drug\n- soybean preparation, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- vitamin E, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- soy protein isolate, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- cannabidiol 100 MG/ML Oral Solution, through Topical route, with intended 0 refill(s). Instructions: by Topical route Compounded cream for inflammation\n- soybean allergenic extract, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- folic acid, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- aspirin 81 MG / calcium carbonate 777 MG Oral Tablet, through Oral route, presumably until 2019-05-10, with intended 0 refill(s). Instructions: take 81 mg by mouth daily\n- triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2022-02-12, with intended 0 refill(s). Instructions: 2 Sprays by Nasal route every day\n- wheat germ oil, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- alpha tocopherol, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- valacyclovir 500 MG Oral Tablet, through Oral route, presumably until 2020-01-03, with intended 0 refill(s). Instructions: take 500 mg by mouth 2 times a day as needed\n- vitamin B complex, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-06-06 00:00:00, ended at 2019-06-06 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Generalized anxiety disorder\n- Mild intermittent asthma\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, started on 2019-06-07, presumably until 2020-07-31, with intended 1 refill(s). Instructions: TAKE 1 TO 2 TABLETS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n- NDA201739 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2019-06-07, presumably until 2021-06-21, with intended 6 refill(s). Instructions: USE AS DIRECTED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-25 00:00:00, ended at 2019-07-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2019-07-26, presumably until 2020-01-08, with intended 2 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-12 00:00:00, ended at 2019-10-12 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, started on 2019-10-12, presumably until 2020-07-31, with intended 11 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-02 00:00:00, ended at 2020-01-02 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2020-01-03, presumably until 2020-07-31, with intended 1 refill(s). Instructions: 1T 2 TIMES A DAY FOR 1 MONTH DURING BREAKOUT\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-07 00:00:00, ended at 2020-01-07 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-08, presumably until 2020-01-25, with intended 3 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-17 00:00:00, ended at 2020-01-17 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Asteatosis cutis\n- Primary diagnosis: Disorder of skin and/or subcutaneous tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-22 00:00:00, ended at 2020-01-22 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-23, presumably until 2020-01-23, with intended 2 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-25 15:31:41, ended at 2020-01-25 16:25:04\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute pansinusitis\n- Benign neoplasm of adrenal gland\n- Allergic rhinitis\n\n### Drug\n- doxycycline hyclate 100 MG Oral Capsule, through Oral route, started on 2020-01-25, presumably until 2020-02-01, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day for 7 days\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-25, presumably until 2021-07-29, with intended 3 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-29 10:04:04, ended at 2020-02-29 10:27:09\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of adrenal gland\n\n### Drug\n- dexamethasone 1 MG Oral Tablet, started on 2020-02-29, presumably until 2020-10-01, with intended 1 refill(s). Instructions: 1 tab at 11 pm\n- carvedilol 25 MG Oral Tablet, through Oral route, started on 2020-02-09, presumably until 2020-02-09, with intended 0 refill(s). Instructions: Take 1 tablet (25 mg total) by mouth Takes 1 1/2 tab daily\n- 120 ACTUAT budesonide 0.08 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, started on 2020-02-22, presumably until 2021-02-19, with intended 0 refill(s)\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, started on 2020-02-21, presumably until 2020-10-01, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-01 00:00:00, ended at 2020-03-01 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of adrenal gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-07 00:00:00, ended at 2020-03-07 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2020-03-07, presumably until 2021-02-19, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-07 00:00:00, ended at 2020-03-07 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-30 00:00:00, ended at 2020-04-30 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2020-04-30, presumably until 2020-06-03, with intended 1 refill(s). Instructions: Apply one patch daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-30 00:00:00, ended at 2020-04-30 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2020-04-30, presumably until 2020-04-30, with intended 1 refill(s). Instructions: Apply one patch daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-03 00:00:00, ended at 2020-06-03 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2020-06-03, presumably until 2021-02-05, with intended 6 refill(s). Instructions: Apply one patch daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-14 00:00:00, ended at 2020-06-14 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cardiomyopathy\n\n### Drug\n- bumetanide 0.5 MG Oral Tablet, started on 2020-06-14, presumably until 2022-01-04, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH DAILY AS NEEDED for swelling (please allow 48 hours for refills)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-31 00:00:00, ended at 2020-07-31 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, started on 2020-08-01, presumably until 2021-01-09, with intended 11 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-31 00:00:00, ended at 2020-07-31 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2020-08-01, presumably until 2021-06-21, with intended 1 refill(s). Instructions: take 1-2 Tabs (0.5-1 mg total) by mouth every 4 hours as needed\n- valacyclovir 500 MG Oral Tablet, started on 2020-08-01, presumably until 2021-01-09, with intended 1 refill(s). Instructions: 1To 2 TIMES A DAY FOR 1 MONTH DURING BREAKOUT\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-17 09:25:05, ended at 2020-09-17 09:54:27\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 45.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Cortisol Free [Mass/time] in 24 hour Urine: 15 (microgram per 24 hours)\n- Cortisol Free [Mass/volume] in Urine: 5 (microgram per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Metanephrine Free [Mass/volume] in Serum or Plasma: 15.4 (picogram per milliliter)\n- Body height: 5' 1\" (inch (US))\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Normetanephrine [Mass/volume] in Serum or Plasma: 101.4 (picogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of adrenal gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-27 00:00:00, ended at 2020-09-27 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sleep apnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-01 10:21:33, ended at 2020-10-01 10:47:25\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of adrenal gland\n- Steatosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-16 00:00:00, ended at 2020-12-16 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chalazion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-09 00:00:00, ended at 2021-01-09 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2021-01-09, presumably until 2021-06-21, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 2 TIMES A DAY FOR ONE MONTH DURING BREAKOUT\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, started on 2021-01-09, presumably until 2021-06-21, with intended 10 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-07 00:00:00, ended at 2021-02-07 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sciatica\n\n### Drug\n- No drugs.\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Hyperlipidemia within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-02-25 00:00:00, ended at 2012-02-25 00:00:00\nThe patient in this visit was 36 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 25 MG Oral Tablet, through Oral route, started on 2012-02-25, presumably until 2019-05-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-02-26 00:00:00, ended at 2012-02-26 00:00:00\nThe patient in this visit was 36 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR bupropion hydrochloride 300 MG Extended Release Oral Tablet, started on 2012-02-26, presumably until 2013-02-07, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-01-16 00:00:00, ended at 2013-01-16 00:00:00\nThe patient in this visit was 37 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 113 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 197 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.73 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.2 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 82 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 0.779 (micro-international unit per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 27 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.5 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 57 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Primary cardiomyopathy\n- Primary diagnosis: Non-toxic multinodular goiter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-07 14:01:58, ended at 2013-02-07 14:47:43\nThe patient in this visit was 37 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n- General examination of patient\n\n### Condition\n- Attention deficit hyperactivity disorder, predominantly inattentive type\n- Non-toxic multinodular goiter\n- Chronic nonalcoholic liver disease\n- Sleep apnea\n- Bipolar disorder\n- Primary cardiomyopathy\n\n### Drug\n- lurasidone hydrochloride 40 MG Oral Tablet, through Oral route, presumably until 2014-06-21. Instructions: take  by mouth. Split in 1/4 daily\n- lurasidone hydrochloride 20 MG Oral Tablet, through Oral route, presumably until 2014-06-21. Instructions: take  by mouth. Split in 1/4 daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-21 16:51:40, ended at 2014-06-21 17:20:47\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic nonalcoholic liver disease\n- Primary diagnosis: Non-toxic multinodular goiter\n- Bipolar disorder\n- Primary cardiomyopathy\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2014-06-21, presumably until 2015-08-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-10-04 00:00:00, ended at 2014-10-04 00:00:00\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2014-10-04, presumably until 2015-10-25, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-04-17 14:39:32, ended at 2015-04-17 15:09:27\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (international unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.2 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 83 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.9 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.5 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 0.679 (micro-international unit per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.8 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 27.9 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Body height: 5' 1\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-toxic multinodular goiter\n- Chronic nonalcoholic liver disease\n- Primary cardiomyopathy\n- Primary diagnosis: Dysfunction of eustachian tube\n\n### Drug\n- ethacrynic acid 25 MG Oral Tablet, through Oral route, presumably until 2015-10-25, with intended 0 refill(s). Instructions: take 2 Tabs by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-04-19 00:00:00, ended at 2015-04-19 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-05-01 00:00:00, ended at 2015-05-01 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2015-05-01, presumably until 2016-05-01, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-01 13:57:32, ended at 2015-05-01 14:38:58\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Non-toxic multinodular goiter\n- Bipolar disorder\n- Sleep apnea\n- Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-05 00:00:00, ended at 2015-08-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-toxic multinodular goiter\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2015-08-05, presumably until 2015-09-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-30 00:00:00, ended at 2015-08-30 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-toxic multinodular goiter\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2015-09-02, presumably until 2016-05-01, with intended 6 refill(s). Instructions: take 1 Tab by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-25 00:00:00, ended at 2015-10-25 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2015-10-25, presumably until 2017-04-09, with intended 6 refill(s). Instructions: Use as directed\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2015-10-25, presumably until 2017-04-09, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-25 10:07:18, ended at 2015-10-25 11:09:46\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Attention deficit hyperactivity disorder\n- Posttraumatic stress disorder\n\n### Drug\n- triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2019-05-10, with intended 0 refill(s). Instructions: 55 mcg by Nasal route daily\n- bumetanide 0.5 MG Oral Tablet, started on 2015-10-25, presumably until 2017-07-20, with intended 3 refill(s). Instructions: Take 1 po daily prn swelling\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (81 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-27 13:41:10, ended at 2016-02-27 14:07:45\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-18 00:00:00, ended at 2016-03-18 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-24 09:59:32, ended at 2016-03-24 11:15:21\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-14 09:42:59, ended at 2016-04-14 10:14:56\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-05-01 00:00:00, ended at 2016-05-01 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2016-05-01, presumably until 2016-12-16, with intended 6 refill(s). Instructions: take 1 Tab by mouth Every Day\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2016-05-01, presumably until 2016-05-08, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-07 00:00:00, ended at 2016-05-07 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Biceps tendinitis\n- Shoulder joint pain\n- Nontraumatic rotator cuff tear\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-13 09:29:30, ended at 2016-05-13 10:06:48\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cardiomyopathy\n- Primary diagnosis: Acute bronchitis\n- Non-toxic multinodular goiter\n- Sleep apnea\n\n### Drug\n- 14 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2016-05-13, presumably until 2017-05-13, with intended 3 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-07-10 00:00:00, ended at 2016-07-10 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anesthesia of skin\n- Primary diagnosis: Low back pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-13 10:27:49, ended at 2016-11-13 11:24:59\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-toxic multinodular goiter\n- Primary diagnosis: Cardiomyopathy\n- Attention deficit hyperactivity disorder\n- Mixed bipolar I disorder in full remission\n- Mild intermittent asthma\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2016-11-13, presumably until 2017-11-13, with intended 3 refill(s). Instructions: apply 1 Patch to skin daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-16 00:00:00, ended at 2016-12-16 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2016-12-16, presumably until 2018-04-21, with intended 11 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-09 00:00:00, ended at 2017-04-09 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-04-09, presumably until 2018-07-26, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-09 00:00:00, ended at 2017-04-09 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2017-04-09, presumably until 2017-12-07, with intended 6 refill(s). Instructions: Use as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-30 10:51:26, ended at 2017-04-30 11:28:27\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Attention deficit hyperactivity disorder\n- Non-toxic multinodular goiter\n- Sleep apnea\n- Impaired glucose tolerance\n- Mixed bipolar I disorder in full remission\n- Primary diagnosis: Cardiomyopathy\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-07-02 00:00:00, ended at 2017-07-02 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-toxic uninodular goiter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-20 00:00:00, ended at 2017-07-20 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bumetanide 0.5 MG Oral Tablet, started on 2017-07-21, presumably until 2019-04-07, with intended 3 refill(s). Instructions: Take one tablet by mouth daily as needed for swelling.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-27 00:00:00, ended at 2017-07-27 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-07-28, presumably until 2017-08-04, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-09-22 00:00:00, ended at 2017-09-22 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- No conditions.\n\n### Drug\n- 1 ML hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe, through Intramuscular route, started on 2017-09-23, presumably until 2017-09-24, with intended 0 refill(s). Instructions: inject 1 mL into a muscle One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-09-24 00:00:00, ended at 2017-09-24 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-08 13:54:03, ended at 2017-10-08 13:54:21\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-10-26 00:00:00, ended at 2017-10-26 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.5 ML typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe, started on 2017-10-26, presumably until 2018-04-21, with intended 0 refill(s). Instructions: Injection 0.5 mL into the muscle One Time\n- 0.5 ML Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML Prefilled Syringe, through Intramuscular route, started on 2017-10-26, presumably until 2017-10-27, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle as directed\n- atovaquone 250 MG / proguanil hydrochloride 100 MG Oral Tablet, started on 2017-10-26, presumably until 2018-04-21, with intended 0 refill(s). Instructions: Take 1 tab po starting 1-2 days before trip,continue till one week after returning from trip\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-11-04 00:00:00, ended at 2017-11-04 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2017-11-04, presumably until 2018-04-21, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-07 00:00:00, ended at 2017-12-07 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2017-12-08, presumably until 2019-06-06, with intended 6 refill(s). Instructions: Use as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-12-13 00:00:00, ended at 2017-12-13 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sleep apnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-21 14:13:18, ended at 2018-04-21 14:51:16\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sleep apnea\n- Cardiomyopathy\n- Primary diagnosis: Acute maxillary sinusitis\n- Bipolar disorder in remission\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2018-04-21, presumably until 2019-06-06, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 4 to 6 hours as needed\n- ergocalciferol 1.25 MG Oral Capsule, through Oral route, started on 2018-04-21, presumably until 2020-01-25, with intended 3 refill(s). Instructions: take 1 Cap by mouth every 7 days\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2018-04-21, presumably until 2018-05-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n- valacyclovir 500 MG Oral Tablet, through Oral route, presumably until 2018-08-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day For 1 month during breakout\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-26 00:00:00, ended at 2018-07-26 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mild intermittent asthma\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2018-07-27, presumably until 2019-10-12, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-08-22 00:00:00, ended at 2018-08-22 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2018-08-22, presumably until 2019-03-25, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 30 days For 1 month during breakout\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-18 00:00:00, ended at 2018-10-18 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2018-10-18, presumably until 2019-07-25, with intended 3 refill(s). Instructions: USE IN EACH NOSTRIL AS DIRECTED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-03-14 00:00:00, ended at 2019-03-14 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney stone\n- Sleep apnea\n- Steatosis of liver\n- Uncomplicated asthma\n- Primary diagnosis: Urticaria due to cold and heat\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-25 00:00:00, ended at 2019-03-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ophthalmic herpes simplex\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2019-03-28, presumably until 2019-04-27, with intended 2 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 2 TIMES A DAY FOR 1 MONTH DURING BREAKOUT\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-07 00:00:00, ended at 2019-04-07 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cardiomyopathy\n\n### Drug\n- bumetanide 0.5 MG Oral Tablet, started on 2019-04-07, presumably until 2020-06-14, with intended 3 refill(s). Instructions: Take one tablet by mouth daily as needed for swelling.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-10 10:43:15, ended at 2019-05-10 14:22:35\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Sleep apnea\n- Cardiomyopathy\n\n### Drug\n- soybean preparation, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- vitamin E, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- soy protein isolate, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- cannabidiol 100 MG/ML Oral Solution, through Topical route, with intended 0 refill(s). Instructions: by Topical route Compounded cream for inflammation\n- soybean allergenic extract, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- folic acid, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- aspirin 81 MG / calcium carbonate 777 MG Oral Tablet, through Oral route, presumably until 2019-05-10, with intended 0 refill(s). Instructions: take 81 mg by mouth daily\n- triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2022-02-12, with intended 0 refill(s). Instructions: 2 Sprays by Nasal route every day\n- wheat germ oil, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- alpha tocopherol, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- valacyclovir 500 MG Oral Tablet, through Oral route, presumably until 2020-01-03, with intended 0 refill(s). Instructions: take 500 mg by mouth 2 times a day as needed\n- vitamin B complex, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-06-06 00:00:00, ended at 2019-06-06 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Generalized anxiety disorder\n- Mild intermittent asthma\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, started on 2019-06-07, presumably until 2020-07-31, with intended 1 refill(s). Instructions: TAKE 1 TO 2 TABLETS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n- NDA201739 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2019-06-07, presumably until 2021-06-21, with intended 6 refill(s). Instructions: USE AS DIRECTED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-25 00:00:00, ended at 2019-07-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2019-07-26, presumably until 2020-01-08, with intended 2 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-12 00:00:00, ended at 2019-10-12 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, started on 2019-10-12, presumably until 2020-07-31, with intended 11 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-02 00:00:00, ended at 2020-01-02 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2020-01-03, presumably until 2020-07-31, with intended 1 refill(s). Instructions: 1T 2 TIMES A DAY FOR 1 MONTH DURING BREAKOUT\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-07 00:00:00, ended at 2020-01-07 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-08, presumably until 2020-01-25, with intended 3 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-17 00:00:00, ended at 2020-01-17 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Asteatosis cutis\n- Primary diagnosis: Disorder of skin and/or subcutaneous tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-22 00:00:00, ended at 2020-01-22 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-23, presumably until 2020-01-23, with intended 2 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-25 15:31:41, ended at 2020-01-25 16:25:04\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute pansinusitis\n- Benign neoplasm of adrenal gland\n- Allergic rhinitis\n\n### Drug\n- doxycycline hyclate 100 MG Oral Capsule, through Oral route, started on 2020-01-25, presumably until 2020-02-01, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day for 7 days\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-25, presumably until 2021-07-29, with intended 3 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-29 10:04:04, ended at 2020-02-29 10:27:09\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of adrenal gland\n\n### Drug\n- dexamethasone 1 MG Oral Tablet, started on 2020-02-29, presumably until 2020-10-01, with intended 1 refill(s). Instructions: 1 tab at 11 pm\n- carvedilol 25 MG Oral Tablet, through Oral route, started on 2020-02-09, presumably until 2020-02-09, with intended 0 refill(s). Instructions: Take 1 tablet (25 mg total) by mouth Takes 1 1/2 tab daily\n- 120 ACTUAT budesonide 0.08 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, started on 2020-02-22, presumably until 2021-02-19, with intended 0 refill(s)\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, started on 2020-02-21, presumably until 2020-10-01, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-01 00:00:00, ended at 2020-03-01 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of adrenal gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-07 00:00:00, ended at 2020-03-07 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2020-03-07, presumably until 2021-02-19, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-07 00:00:00, ended at 2020-03-07 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-30 00:00:00, ended at 2020-04-30 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2020-04-30, presumably until 2020-06-03, with intended 1 refill(s). Instructions: Apply one patch daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-30 00:00:00, ended at 2020-04-30 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2020-04-30, presumably until 2020-04-30, with intended 1 refill(s). Instructions: Apply one patch daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-03 00:00:00, ended at 2020-06-03 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2020-06-03, presumably until 2021-02-05, with intended 6 refill(s). Instructions: Apply one patch daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-14 00:00:00, ended at 2020-06-14 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cardiomyopathy\n\n### Drug\n- bumetanide 0.5 MG Oral Tablet, started on 2020-06-14, presumably until 2022-01-04, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH DAILY AS NEEDED for swelling (please allow 48 hours for refills)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-31 00:00:00, ended at 2020-07-31 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, started on 2020-08-01, presumably until 2021-01-09, with intended 11 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-31 00:00:00, ended at 2020-07-31 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2020-08-01, presumably until 2021-06-21, with intended 1 refill(s). Instructions: take 1-2 Tabs (0.5-1 mg total) by mouth every 4 hours as needed\n- valacyclovir 500 MG Oral Tablet, started on 2020-08-01, presumably until 2021-01-09, with intended 1 refill(s). Instructions: 1To 2 TIMES A DAY FOR 1 MONTH DURING BREAKOUT\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-17 09:25:05, ended at 2020-09-17 09:54:27\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 45.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Cortisol Free [Mass/time] in 24 hour Urine: 15 (microgram per 24 hours)\n- Cortisol Free [Mass/volume] in Urine: 5 (microgram per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Metanephrine Free [Mass/volume] in Serum or Plasma: 15.4 (picogram per milliliter)\n- Body height: 5' 1\" (inch (US))\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Normetanephrine [Mass/volume] in Serum or Plasma: 101.4 (picogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of adrenal gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-27 00:00:00, ended at 2020-09-27 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sleep apnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-01 10:21:33, ended at 2020-10-01 10:47:25\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of adrenal gland\n- Steatosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-16 00:00:00, ended at 2020-12-16 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chalazion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-09 00:00:00, ended at 2021-01-09 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2021-01-09, presumably until 2021-06-21, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 2 TIMES A DAY FOR ONE MONTH DURING BREAKOUT\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, started on 2021-01-09, presumably until 2021-06-21, with intended 10 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-07 00:00:00, ended at 2021-02-07 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sciatica\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Hyperlipidemia within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of hyperlipidemia means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "5a54a251c8fab7ff4520c8d2bb85622cc73b5c225566671138e0a6db41926e31", "prompt_hash": "fef8c91a0ecc21a12e14f347471d7c577cc55bb3be1430d7991f0442008fab11", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 7, "doc": {"person_id": 115968044, "visit_occurrence_id": 40081595, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2010-07-05 08:11:00", "visit_end_datetime": "2010-07-05 23:59:00", "visit_length_in_hours": 15.8, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-05 08:11:00, ended at 2010-07-05 23:59:00\nThe patient in this visit was 26 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Disorder of bone and articular cartilage\n- Joint pain\n- Primary malignant neoplasm of long bone of lower limb\n- Amputated above knee\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 114, "patient_first_visit_date": "2008-10-07 00:00:00", "patient_last_visit_date": "2011-07-05 08:37:00", "end_obs_date": "2011-07-05", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 9, "cumulated_visit_num": 9, "cumulated_approximate_token_count": 4322, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2008-10-07 00:00:00, ended at 2008-10-07 00:00:00\nThe patient in this visit was 24 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.3 (percent)\n- MCV [Entitic volume] by Automated count: 87.5 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.74 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.95 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.84 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.7 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-10-08 05:20:00, ended at 2008-10-11 12:30:00\nThe patient in this visit was 24 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.0 (thousand per microliter)\n- Prothrombin time (PT): 22.9 (second)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.1 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.01 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 2.17 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.8 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.51 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 39.7 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 195 (thousand per microliter)\n- Body height: 6' 1\" (inch (US))\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.07 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of long bone of lower limb\n- Acute posthemorrhagic anemia\n- Pulmonary embolism with pulmonary infarction\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2008-10-08, presumably until 2008-10-08\n- 1 ML meperidine hydrochloride 25 MG/ML Cartridge, started on 2008-10-08, presumably until 2008-10-08\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2008-10-08, presumably until 2008-10-08\n- lorazepam 1 MG Oral Tablet, through Oral route. Instructions: take 1 mg by mouth as needed \n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2008-10-08, presumably until 2008-11-10, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n- 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2008-10-09, presumably until 2008-10-11\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-10-08, presumably until 2008-10-09\n- 2 ML ondansetron 2 MG/ML Injection, started on 2008-10-08, presumably until 2008-10-10\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2008-10-08, presumably until 2008-10-09\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2008-10-08, presumably until 2008-12-30, with quantity of 20.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- 2 ML metoclopramide 5 MG/ML Injection, started on 2008-10-09, presumably until 2008-10-09\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2008-10-08, presumably until 2008-10-08\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-10-08, presumably until 2008-10-11\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-10-10, presumably until 2008-12-30, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed \n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2008-10-08, presumably until 2008-10-08\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2008-10-09, presumably until 2008-11-10, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- warfarin sodium 6 MG Oral Tablet, through Oral route, started on 2008-10-10, presumably until 2008-10-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-11-10 07:03:00, ended at 2008-11-10 12:17:00\nThe patient in this visit was 24 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of long bone of lower limb\n\n### Drug\n- hydromorphone hydrochloride 4 MG Oral Tablet, through Oral route, presumably until 2008-12-30. Instructions: take by mouth as needed \n- 1 ML hydromorphone hydrochloride 4 MG/ML Injection, presumably until 2008-12-30. Instructions: by Injection route as needed \n- 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route. Instructions: by SUBCUTANEOUS route 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-30 00:00:00, ended at 2008-12-30 00:00:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.46 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.49 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 279 (thousand per microliter)\n- Prothrombin time (PT): 13.1 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.3 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 24.7 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-01-05 05:59:00, ended at 2009-01-08 12:05:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 20.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 38 (percent)\n- Platelets [#/volume] in Blood by Automated count: 212 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 31 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.97 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.54 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 2.61 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.8 (thousand per microliter)\n- Body height: 6' 1\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.56 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 25 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 2.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 43.3 (percent)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 28.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of long bone of lower limb\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-01-05, presumably until 2009-01-06\n- mirtazapine 15 MG Oral Tablet, through Oral route, started on 2009-01-06, presumably until 2009-01-07. Instructions: take 7.5 mg by mouth daily. \n- 12 HR oxycodone hydrochloride 20 MG Extended Release Oral Tablet, through Oral route, started on 2009-01-05, presumably until 2009-07-07, with quantity of 42.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- cefazolin 1000 MG Injection, through Intravenous route, started on 2009-01-05, presumably until 2009-01-06\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2009-01-05, presumably until 2009-01-07. Instructions: take 1 mg by mouth as needed \n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2009-01-05, presumably until 2009-01-06\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-01-05, presumably until 2009-01-08\n- dronabinol 5 MG Oral Capsule, through Oral route, started on 2009-01-05, presumably until 2009-01-07. Instructions: take by mouth 3 times a day as needed\n- 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-01-06, presumably until 2009-01-08. Instructions: by SUBCUTANEOUS route 2 times a day.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-01-06, presumably until 2009-01-06\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-01-05, presumably until 2009-01-06\n- morphine sulfate 1 MG/ML Injection, through Intravenous route, started on 2009-01-05, presumably until 2009-01-06\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-01-08, presumably until 2009-07-07, with quantity of 50.0, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-29 13:08:00, ended at 2009-09-29 23:59:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Primary malignant neoplasm\n- Malignant neoplasm of skeletal system\n- Primary malignant neoplasm of soft tissues of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-12 09:35:00, ended at 2010-01-12 23:59:00\nThe patient in this visit was 26 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Abnormal finding on evaluation procedure\n- Malignant neoplasm of skeletal system\n- Primary malignant neoplasm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-07 09:08:00, ended at 2010-04-07 23:59:00\nThe patient in this visit was 26 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Malignant neoplasm of skeletal system\n- Traumatic amputation of lower extremity\n- Primary malignant neoplasm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-05 08:11:00, ended at 2010-07-05 23:59:00\nThe patient in this visit was 26 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Disorder of bone and articular cartilage\n- Joint pain\n- Primary malignant neoplasm of long bone of lower limb\n- Amputated above knee\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Hyperlipidemia within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-10-07 00:00:00, ended at 2008-10-07 00:00:00\nThe patient in this visit was 24 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.3 (percent)\n- MCV [Entitic volume] by Automated count: 87.5 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.74 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.95 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.84 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.7 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-10-08 05:20:00, ended at 2008-10-11 12:30:00\nThe patient in this visit was 24 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.0 (thousand per microliter)\n- Prothrombin time (PT): 22.9 (second)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.1 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.01 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 2.17 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.8 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.51 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 39.7 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 195 (thousand per microliter)\n- Body height: 6' 1\" (inch (US))\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.07 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of long bone of lower limb\n- Acute posthemorrhagic anemia\n- Pulmonary embolism with pulmonary infarction\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2008-10-08, presumably until 2008-10-08\n- 1 ML meperidine hydrochloride 25 MG/ML Cartridge, started on 2008-10-08, presumably until 2008-10-08\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2008-10-08, presumably until 2008-10-08\n- lorazepam 1 MG Oral Tablet, through Oral route. Instructions: take 1 mg by mouth as needed \n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2008-10-08, presumably until 2008-11-10, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n- 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2008-10-09, presumably until 2008-10-11\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-10-08, presumably until 2008-10-09\n- 2 ML ondansetron 2 MG/ML Injection, started on 2008-10-08, presumably until 2008-10-10\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2008-10-08, presumably until 2008-10-09\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2008-10-08, presumably until 2008-12-30, with quantity of 20.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- 2 ML metoclopramide 5 MG/ML Injection, started on 2008-10-09, presumably until 2008-10-09\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2008-10-08, presumably until 2008-10-08\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-10-08, presumably until 2008-10-11\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-10-10, presumably until 2008-12-30, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed \n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2008-10-08, presumably until 2008-10-08\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2008-10-09, presumably until 2008-11-10, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- warfarin sodium 6 MG Oral Tablet, through Oral route, started on 2008-10-10, presumably until 2008-10-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-11-10 07:03:00, ended at 2008-11-10 12:17:00\nThe patient in this visit was 24 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of long bone of lower limb\n\n### Drug\n- hydromorphone hydrochloride 4 MG Oral Tablet, through Oral route, presumably until 2008-12-30. Instructions: take by mouth as needed \n- 1 ML hydromorphone hydrochloride 4 MG/ML Injection, presumably until 2008-12-30. Instructions: by Injection route as needed \n- 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route. Instructions: by SUBCUTANEOUS route 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-30 00:00:00, ended at 2008-12-30 00:00:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.46 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.49 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 279 (thousand per microliter)\n- Prothrombin time (PT): 13.1 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.3 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 24.7 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-01-05 05:59:00, ended at 2009-01-08 12:05:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 20.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 38 (percent)\n- Platelets [#/volume] in Blood by Automated count: 212 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 31 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.97 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.54 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 2.61 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.8 (thousand per microliter)\n- Body height: 6' 1\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.56 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 25 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 2.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 43.3 (percent)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 28.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of long bone of lower limb\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-01-05, presumably until 2009-01-06\n- mirtazapine 15 MG Oral Tablet, through Oral route, started on 2009-01-06, presumably until 2009-01-07. Instructions: take 7.5 mg by mouth daily. \n- 12 HR oxycodone hydrochloride 20 MG Extended Release Oral Tablet, through Oral route, started on 2009-01-05, presumably until 2009-07-07, with quantity of 42.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- cefazolin 1000 MG Injection, through Intravenous route, started on 2009-01-05, presumably until 2009-01-06\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2009-01-05, presumably until 2009-01-07. Instructions: take 1 mg by mouth as needed \n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2009-01-05, presumably until 2009-01-06\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-01-05, presumably until 2009-01-08\n- dronabinol 5 MG Oral Capsule, through Oral route, started on 2009-01-05, presumably until 2009-01-07. Instructions: take by mouth 3 times a day as needed\n- 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-01-06, presumably until 2009-01-08. Instructions: by SUBCUTANEOUS route 2 times a day.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-01-06, presumably until 2009-01-06\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-01-05, presumably until 2009-01-06\n- morphine sulfate 1 MG/ML Injection, through Intravenous route, started on 2009-01-05, presumably until 2009-01-06\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-01-08, presumably until 2009-07-07, with quantity of 50.0, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-29 13:08:00, ended at 2009-09-29 23:59:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Primary malignant neoplasm\n- Malignant neoplasm of skeletal system\n- Primary malignant neoplasm of soft tissues of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-12 09:35:00, ended at 2010-01-12 23:59:00\nThe patient in this visit was 26 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Abnormal finding on evaluation procedure\n- Malignant neoplasm of skeletal system\n- Primary malignant neoplasm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-07 09:08:00, ended at 2010-04-07 23:59:00\nThe patient in this visit was 26 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Malignant neoplasm of skeletal system\n- Traumatic amputation of lower extremity\n- Primary malignant neoplasm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-05 08:11:00, ended at 2010-07-05 23:59:00\nThe patient in this visit was 26 years old, White, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Disorder of bone and articular cartilage\n- Joint pain\n- Primary malignant neoplasm of long bone of lower limb\n- Amputated above knee\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Hyperlipidemia within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of hyperlipidemia means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "c254a001ee48bb21c36a773eae51b70e69d01534063de796472cacfa88740c7d", "prompt_hash": "98f2ed83fa5a5db75f7a5a71b74c3b5020a3a57c0d37727b8c39ca558e47cbc6", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 8, "doc": {"person_id": 115968162, "visit_occurrence_id": 49258395, "death_date": null, "visit_concept_name": "Pharmacy visit", "visit_start_datetime": "2012-08-05 00:00:00", "visit_end_datetime": "2012-08-05 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Pharmacy visit, started at 2012-08-05 00:00:00, ended at 2012-08-05 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valproic acid 50 MG/ML Oral Solution, started on 2012-08-05, presumably until 2012-08-05, with intended 11 refill(s). Instructions: GIVE VIA G J-TUBE 15ML (750MG) TWICE DAILY AT 8AM & 4PM BEFORE MEALS  THEN 20ML (1000MG) AT 10PM.\n\n", "approximate_token_count": 134, "patient_first_visit_date": "2009-02-16 00:00:00", "patient_last_visit_date": "2015-11-10 00:00:00", "end_obs_date": "2013-08-05", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "recurrent", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 17, "cumulated_visit_num": 17, "cumulated_approximate_token_count": 18061, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2009-02-16 00:00:00, ended at 2009-02-16 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 156 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.30 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.7 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Globulin [Mass/volume] in Serum: 5.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.88 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Valproate [Mass/volume] in Serum or Plasma: 110.1 (microgram per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.10 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.4 (femtoliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-11-02 23:01:00, ended at 2011-11-08 16:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 35 (millimole per liter)\n- Iron [Mass/volume] in Serum or Plasma: 30 (microgram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 481 (unit per liter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 13.8 (microgram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 21.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.5 (thousand per microliter)\n- Erythrocyte sedimentation rate: 134 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 159 (microgram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 45 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 149 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 3 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.08 (milli-international unit per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: >1000 (picogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 946 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.1 (percent)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 19 (percent)\n- MCV [Entitic volume] by Automated count: 97.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 2.4 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 9.0 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: Result checked (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.8 (nanogram per deciliter)\n- Valproate [Mass/volume] in Serum or Plasma: 33.1 (microgram per milliliter)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Monocytes/100 leukocytes in Blood by Manual count: 8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 330 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Globulin [Mass/volume] in Serum: 5.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 19 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.2 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 16.5 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n\n### Procedure\n- Prophylactic administration of vaccine against other diseases\n- Echocardiography\n- Molecular diagnostics; isolation or extraction of highly purified nucleic acid, each nucleic acid type (ie, DNA or RNA)\n- Molecular diagnostics; amplification, target, multiplex, first 2 nucleic acid sequences\n- Molecular diagnostics; reverse transcription\n- Molecular diagnostics; interpretation and report\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; subsequent\n- Radiologic examination, chest; single view, frontal\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Molecular diagnostics; amplification, target, multiplex, each additional nucleic acid sequence beyond 2 (List separately in addition to code for primary procedure)\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Molecular diagnostics; separation by gel electrophoresis (eg, agarose, polyacrylamide), each nucleic acid preparation\n- Radiologic examination, chest, special views (eg, lateral decubitus, Bucky studies)\n- Collection of venous blood by venipuncture\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; initial demonstration and/or evaluation\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Essential hypertension\n- Seizure disorder\n- Disorder of pericardium\n- Cardiomegaly\n- Fever\n- Acute renal failure syndrome\n- Leukocytosis\n- Physiological development failure\n- Pleural effusion\n- Atelectasis\n- Acquired hypothyroidism\n- Disorder of magnesium metabolism\n- Iron deficiency anemia\n- Cerebral palsy\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2011-11-05, presumably until 2011-11-08\n- divalproex sodium 250 MG Delayed Release Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- atenolol 50 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-07\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- sodium chloride 100 MG/ML Inhalation Solution, through Inhalation, started on 2011-11-05, presumably until 2011-11-08\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-07\n- miconazole nitrate 0.02 MG/MG Topical Ointment, through Topical route, started on 2011-11-06, presumably until 2011-11-08\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-11-03, presumably until 2011-11-05\n- gabapentin 400 MG Oral Capsule, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2011-11-03, presumably until 2011-11-08\n- lacosamide 100 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- calcium carbonate 1250 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-12 13:34:00, ended at 2011-11-12 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Fever\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-11-15 00:00:00, ended at 2011-11-15 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Fever\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2011-11-16 07:24:00, ended at 2011-12-08 10:30:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.54 (million per microliter)\n- Globulin [Mass/volume] in Serum: 6.2 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 299 (unit per liter)\n- MCH [Entitic mass] by Automated count: 33.2 (picogram)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 2.27 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 678 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Valproate [Mass/volume] in Serum or Plasma: 50.6 (microgram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 0.99 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 3.9 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 22.6 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Body height: 5' 2\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 3.13 (thousand per microliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 1.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 21 (percent)\n- Monocytes/100 leukocytes in Blood by Manual count: 3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 308 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 38.6 (second)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 17.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 67 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Prothrombin time (PT): 15.4 (second)\n- Reticulocytes [#/volume] in Blood by Automated count: 47.9 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: <5 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 134 (millimeter per hour)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.3 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: <1 (nanogram per milliliter)\n- MCV [Entitic volume] by Automated count: 95.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.02 (thousand per microliter)\n\n### Procedure\n- Counseling\n- Pericardiocentesis\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Other incision of pleura\n- Molecular diagnostics; enzymatic digestion, each enzyme treatment\n- Computed tomographic angiography, neck, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Echocardiography\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Molecular diagnostics; separation by gel electrophoresis (eg, agarose, polyacrylamide), each nucleic acid preparation\n- Tube thoracostomy, includes connection to drainage system (eg, water seal), when performed, open (separate procedure)\n- Pericardiocentesis; initial\n- Molecular diagnostics; interpretation and report\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Replacement of gastrostomy or cecostomy (or other colonic) tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Radiologic examination, swallowing function, with cineradiography/videoradiography, including scout neck radiograph(s) and delayed image(s), when performed, contrast (eg, barium) study\n- Motion fluoroscopic evaluation of swallowing function by cine or video recording\n- Molecular diagnostics; mutation identification by sequencing, single segment, each segment\n- Biopsy of blood vessel\n- Collection of venous blood by venipuncture\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Occupational therapy evaluation\n- Molecular diagnostics; isolation or extraction of highly purified nucleic acid, each nucleic acid type (ie, DNA or RNA)\n- Evaluation of oral and pharyngeal swallowing function\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Radiologic examination, abdomen; single anteroposterior view\n- Arterial puncture, withdrawal of blood for diagnosis\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiological guidance (ie, fluoroscopy, ultrasound, or computed tomography), for percutaneous drainage (eg, abscess, specimen collection), with placement of catheter, radiological supervision and interpretation\n- Radiologic examination, chest; single view, frontal\n- Packed blood cell transfusion\n\n### Condition\n- Cerebral palsy\n- Disorder of magnesium metabolism\n- Primary malignant neoplasm of colon\n- Disorder of lung\n- Familial Mediterranean fever\n- Temporal arteritis\n- Lung field abnormal\n- Physiological development failure\n- Cardiac arrhythmia\n- Disorder of pericardium\n- Osteoporosis\n- Anemia\n- Leukocytosis\n- Acute renal failure syndrome\n- Hypoxemia\n- Pleural effusion\n- Acquired hypothyroidism\n- Atelectasis\n- Atherosclerosis of aorta\n- Dysphagia\n- Dyspnea\n- Fever\n- Pneumonitis due to inhaled substance\n- Prostatitis\n- Second degree atrioventricular block\n- Acute idiopathic pericarditis\n- Epilepsy\n\n### Drug\n- gabapentin 50 MG/ML Oral Solution, through Oral route, started on 2011-11-19, presumably until 2011-12-06\n- atenolol 50 MG Oral Tablet, through Oral route, started on 2011-12-07, presumably until 2012-01-08, with intended 0 refill(s). Instructions: take 50 mg by mouth daily. Hold for systolic BP below 100, and if heartrate is below 60 BPM \n- methylprednisolone 40 MG Injection, started on 2011-11-27, presumably until 2011-11-30\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-12-07. Instructions: 10 mg by Other route every bedtime. Given Via G-J Tube.\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2011-11-25, presumably until 2011-12-08\n- potassium phosphate, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- tribasic potassium phosphate, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2011-11-21, presumably until 2011-12-01\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2011-11-19, presumably until 2011-11-29\n- lacosamide 200 MG Oral Tablet, through Oral route, started on 2011-11-30, presumably until 2012-04-01. Instructions: 200 mg by Other route 2 times a day. Given via G-J tube\n- alendronic acid 70 MG Oral Tablet, presumably until 2012-06-05. Instructions: 70 mg by Other route once a week. Every Friday Given via G-J tube\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2011-11-25, presumably until 2011-12-08\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-12-08. Instructions: take by mouth 2 times a day.\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-11-17, presumably until 2011-11-17\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2011-12-03, presumably until 2011-12-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- ibuprofen 400 MG Oral Tablet, through Oral route, started on 2011-11-30, presumably until 2011-11-30\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-11-17, presumably until 2011-12-08\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2011-11-19, presumably until 2011-11-19\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2011-11-19, presumably until 2011-11-30\n- tribasic sodium phosphate, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2011-11-22, presumably until 2011-11-22\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-26. Instructions: take by mouth daily.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-11-16, presumably until 2012-04-01. Instructions: 250 mg by Other route daily. Given via G-J tube.\n- gabapentin 400 MG Oral Capsule, through Oral route, started on 2011-11-16, presumably until 2012-04-01, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day.\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2011-11-30, presumably until 2011-12-08. Instructions: take by mouth daily.\n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2011-11-30, presumably until 2011-12-08. Instructions: take by mouth daily.\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2011-11-17, presumably until 2011-11-30\n- colchicine 0.6 MG Oral Tablet, through Oral route, started on 2011-11-29, presumably until 2012-01-08, with intended 5 refill(s). Instructions: take 1 Tab by mouth daily.\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2011-12-03, presumably until 2011-12-08, with intended 0 refill(s). Instructions: take 3 Tabs by mouth daily.\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2011-11-20, presumably until 2011-11-24\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2011-11-17, presumably until 2011-11-29\n- lacosamide 100 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-17\n- valproic acid 50 MG/ML Oral Solution, through Oral route, started on 2011-11-30, presumably until 2012-01-08, with intended 5 refill(s). Instructions: take 15 mL by mouth every morning.\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2011-11-16, presumably until 2011-11-16\n- sodium phosphate, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- sodium phosphate, monobasic, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- 2 ML ondansetron 2 MG/ML Injection, started on 2011-11-17, presumably until 2011-11-19\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2011-11-16, presumably until 2011-11-16\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-11-17, presumably until 2011-11-21\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2011-11-30, presumably until 2011-11-30\n- sodium phosphate, dibasic, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- lamotrigine 25 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-22. Instructions: take 25 mg by mouth every other day.\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2011-11-30, presumably until 2011-12-08\n- 2 ML diazepam 5 MG/ML Auto-Injector, started on 2011-11-24, presumably until 2011-12-01\n- divalproex sodium 500 MG Delayed Release Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-17. Instructions: take 500 mg by mouth 2 times a day.\n- nystatin 100 UNT/MG Topical Powder, through Topical route, started on 2011-12-05, presumably until 2011-12-05\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2011-11-23, presumably until 2011-11-29\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2011-12-01, presumably until 2011-12-02\n- calcium carbonate 1250 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2012-02-25. Instructions: take 1 Tab by mouth daily. 500 mg 3 times a day \n- dibasic sodium phosphate heptahydrate, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2011-12-03, presumably until 2012-01-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth Q12H.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-11-21, presumably until 2011-12-02\n- dibasic potassium phosphate, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- albuterol 0.83 MG/ML Inhalation Solution, through Inhalation, started on 2011-11-29, presumably until 2011-12-04\n- 1 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-11-16, presumably until 2011-11-16\n- 300 ML linezolid 2 MG/ML Injection, through Intravenous route, started on 2011-11-17, presumably until 2011-11-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-11-16 08:39:08, ended at 2011-11-16 12:45:17\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Disorder of pericardium\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-20 10:20:21, ended at 2011-11-20 16:50:18\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Disorder of pericardium\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-11-30 08:06:54, ended at 2011-11-30 14:56:55\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Disorder of pericardium\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-12-06 15:05:29, ended at 2011-12-06 15:35:19\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Disorder of pericardium\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-12-14 00:00:00, ended at 2011-12-14 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Prostatitis\n- Epilepsy\n- Anemia\n- Leukocytosis\n- Cerebral palsy\n\n### Drug\n- polyethylene glycol 3350 420000 MG / potassium chloride 1480 MG / sodium bicarbonate 5720 MG / sodium chloride 11200 MG Powder for Oral Solution, through Oral route, started on 2011-12-14, presumably until 2012-02-25, with intended 0 refill(s). Instructions: take 420 g by mouth as directed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2011-12-16 19:06:00, ended at 2012-01-08 13:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Base excess in Blood by calculation: 1.0 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.27 (millimole per liter)\n- Iron [Mass/volume] in Serum or Plasma: 55 (microgram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 161 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Manual count: 9 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 42 (percent)\n- Thrombin time: 16.3 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.9 (microgram per milliliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 21 (percent)\n- MCHC [Mass/volume] by Automated count: 36.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Prolactin [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Body height: 5' 4.016\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythropoietin (EPO) [Units/volume] in Serum or Plasma: 128 (milliunit per milliliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1430 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.07 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.86 (thousand per microliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: <5 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Erythrocyte sedimentation rate: 99 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 5.7 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 44 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- MCH [Entitic mass] by Automated count: 35.0 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 28.4 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 1.06 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 29.5 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- MCV [Entitic volume] by Automated count: 97.3 (femtoliter)\n- Osmolality of Serum or Plasma: 327 (milliosmole per kilogram)\n- Prothrombin time (PT): N/A (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.42 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 125 (microgram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.7 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 15.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.5 (percent)\n- Osmolality of Urine: 360 (milliosmole per kilogram)\n- Sodium [Moles/volume] in Serum or Plasma: 155 (millimole per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: N/A (nanogram per deciliter)\n- Valproate [Mass/volume] in Serum or Plasma: 69.6 (microgram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.7 (second)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 3.60 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 490 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.94 (milli-international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 661 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n\n### Procedure\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; initial demonstration and/or evaluation\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Insertion of endotracheal tube\n- Radiologic examination, swallowing function, with cineradiography/videoradiography, including scout neck radiograph(s) and delayed image(s), when performed, contrast (eg, barium) study\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Echocardiography\n- Radiologic examination, abdomen; single anteroposterior view\n- Physical therapy evaluation\n- Conversion of gastrostomy tube to gastro-jejunostomy tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report\n- Packed blood cell transfusion\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Radiologic examination, chest; single view, frontal\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Controlled ventilation procedure and therapy, initiation and management\n- Occupational therapy evaluation\n- Central venous catheter placement with guidance\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Percutaneous [endoscopic] gastrojejunostomy\n- Collection of venous blood by venipuncture\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Counseling\n- Other incision of pleura\n- Continuous invasive mechanical ventilation for less than 96 consecutive hours\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Insertion of gastrostomy tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Therapeutic procedure, 1 or more areas, each 15 minutes; neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Evaluation of oral and pharyngeal swallowing function\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Endoscopic polypectomy of large intestine\n- Motion fluoroscopic evaluation of swallowing function by cine or video recording\n\n### Condition\n- Atelectasis\n- Disorder of pericardium\n- Neoplasm of uncertain behavior of digestive organ\n- Acquired hypothyroidism\n- Hyperosmolality and or hypernatremia\n- Lymphadenopathy\n- Pleural effusion\n- Severe sepsis\n- Sepsis\n- Septic shock\n- Pain in limb\n- Acute renal failure syndrome\n- Anemia\n- Dysphagia\n- Fever\n- Pneumonitis due to inhaled substance\n- Thoracic spondylosis without myelopathy\n- Acute posthemorrhagic anemia\n- Benign neoplasm of colon\n- Cerebral palsy\n- Diarrhea\n- Epilepsy\n- Hypoxemia\n- Leukocytosis\n- Physiological development failure\n- Disorder of magnesium metabolism\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-12-24, presumably until 2012-01-04\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2011-12-26, presumably until 2011-12-28\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2011-12-24, presumably until 2011-12-25\n- clonazepam 0.25 MG Disintegrating Oral Tablet, through Oral route, started on 2012-01-04, presumably until 2012-02-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- 50 ML famotidine 0.4 MG/ML Injection, through Intravenous route, started on 2011-12-19, presumably until 2011-12-21\n- acetaminophen 650 MG Rectal Suppository, through Rectal route, started on 2011-12-29, presumably until 2013-01-07, with intended 1 refill(s). Instructions: insert 1 Suppository into the rectum every 4 hours as needed for Fever.\n- methylprednisolone 40 MG Injection, started on 2011-12-24, presumably until 2012-01-04\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2011-12-28. Instructions: take 10 mg by mouth every bedtime.\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2011-12-17, presumably until 2011-12-21\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2012-01-01, presumably until 2012-01-02\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-01-04, presumably until 2012-01-06\n- lacosamide 200 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2011-12-17. Instructions: take 200 mg by mouth 2 times a day.\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-12-19, presumably until 2011-12-21\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2011-12-27, presumably until 2011-12-28\n- divalproex sodium 125 MG Delayed Release Oral Capsule, through Oral route, started on 2011-12-24, presumably until 2011-12-28\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2011-12-22, presumably until 2011-12-28\n- nystatin 100000 UNT/ML Topical Cream, through Topical route, started on 2011-12-18, presumably until 2012-01-08\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2012-01-01, presumably until 2012-01-04\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2011-12-28\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2011-12-25, presumably until 2012-02-25, with intended 1 refill(s). Instructions: take 3 Tabs by mouth daily. Take 3 tabs per day until 12/20.  On 01/16/2012, start taking 2 tabs per day.  On 01/29/2012, start taking 1 tab per day and continue at this dosage until your appointment with rheumatology.\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-12-24, presumably until 2012-01-02\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2011-12-20, presumably until 2011-12-20\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2011-12-17, presumably until 2012-01-02\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2011-12-29, presumably until 2011-12-29\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2012-01-06, presumably until 2012-02-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Take for another 4 days.\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-12-19, presumably until 2011-12-27\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2011-12-27. Instructions: take by mouth daily.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-12-19, presumably until 2011-12-19. Instructions: take 250 mg by mouth daily.\n- gabapentin 400 MG Oral Capsule, through Oral route, started on 2011-12-17, presumably until 2012-01-08. Instructions: take 400 mg by mouth 3 times a day.\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2011-12-28, presumably until 2011-12-28. Instructions: take by mouth daily.\n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2011-12-28, presumably until 2011-12-28. Instructions: take by mouth daily.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2011-12-17, presumably until 2011-12-24\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2011-12-17, presumably until 2011-12-29\n- colchicine 0.6 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2011-12-28. Instructions: take 1 Tab by mouth daily.\n- ipratropium bromide 0.2 MG/ML Inhalation Solution, through Inhalation, started on 2011-12-29, presumably until 2012-01-05\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2011-12-22, presumably until 2012-01-07\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2011-12-16, presumably until 2011-12-21\n- lacosamide 100 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2012-01-08. Instructions: take 200 mg by mouth 2 times a day.\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2011-12-18, presumably until 2011-12-26\n- valproic acid 50 MG/ML Oral Solution, through Oral route, started on 2011-12-17, presumably until 2012-02-25, with intended 1 refill(s). Instructions: take 20 mL by mouth daily in the evening. Administer via G-tube at 10PM every day.\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2011-12-16, presumably until 2012-01-04\n- clindamycin 300 MG Oral Capsule, through Oral route, started on 2012-01-06, presumably until 2012-02-25, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day. Take for 4 days.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection, through Intravenous route, started on 2011-12-30, presumably until 2011-12-30\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-12-26, presumably until 2011-12-30\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2011-12-16, presumably until 2012-01-03\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-12-29, presumably until 2012-01-03\n- prednisone 50 MG Oral Tablet, through Oral route, started on 2011-12-25, presumably until 2011-12-26\n- levothyroxine sodium 0.075 MG Oral Tablet, through Oral route, started on 2012-01-08, presumably until 2012-02-25, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily.\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2011-12-20, presumably until 2011-12-20\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2011-12-28, presumably until 2012-01-08\n- calcium carbonate 1250 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2011-12-28. Instructions: take 1 Tab by mouth daily. 500 mg 3 times a day \n- midazolam 1 MG/ML Injectable Solution, started on 2011-12-20, presumably until 2011-12-20\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2012-01-04, presumably until 2012-01-06\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2012-01-03, presumably until 2012-01-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-02-25 15:55:00, ended at 2012-02-26 19:17:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 109 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Valproate [Mass/volume] in Serum or Plasma: 54.1 (microgram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Attention to gastrostomy\n- Change of gastrostomy tube, percutaneous, without imaging or endoscopic guidance\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordinat\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Replacement of gastro-jejunostomy tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report\n\n### Condition\n- Seizure\n- Stoma malfunction\n- Physiological development failure\n- Cerebral palsy\n- Epilepsy\n- Mechanical complication of gastrostomy\n- Clinical finding\n\n### Drug\n- polysaccharide iron complex, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous gluconate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous fumarate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous ascorbate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- iron,peptonized, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous succinate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous bisglycinate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous cysteine glycinate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous aspartate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ammonium ferrous sulfate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2012-02-26, presumably until 2012-02-26\n- soy protein-iron complex, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous carbonate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous glycine sulfate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- iron succinyl milk protein complex, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- iron-dextran complex, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- teferrol, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous asparto glycinate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous cacodylate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- valproic acid 50 MG/ML Oral Solution, through Oral route, started on 2012-02-26, presumably until 2012-02-26\n- iron, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous oxalate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-02-25, presumably until 2012-02-25\n- iron sucrose, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous sulfate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- iron carbonyl, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous lactate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous chloride, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- levothyroxine sodium 0.075 MG Oral Tablet. Instructions: 75 mcg by Other route daily. Given via G-J tube. \n- iron sorbitex, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous phosphate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2012-03-30 15:33:00, ended at 2012-04-01 17:13:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Base deficit in Blood: 4.0 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 36.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.75 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Blood by calculation: 2.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bicarbonate [Moles/volume] in Specimen: 20.5 (milliequivalent per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 38.0 (picogram)\n- MCV [Entitic volume] by Automated count: 104.9 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 7.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 27 (percent)\n- Platelets [#/volume] in Blood by Automated count: 74 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Body height: 5' 4\" (inch (US))\n- Globulin [Mass/volume] in Serum: 5.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.77 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 27.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 17.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 51 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Oxygen [Partial pressure] in Blood: 36 (millimeter mercury column)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Carbon dioxide [Partial pressure] in Blood: 34.2 (millimeter mercury column)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.6 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Change of gastrostomy tube\n- Insertion of non-indwelling bladder catheter (eg, straight catheterization for residual urine)\n- Radiologic examination, chest; single view, frontal\n- Radiologic examination, abdomen; single anteroposterior view\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Replacement of gastro-jejunostomy tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Fever\n- Cerebral palsy\n- Vomiting\n- Epilepsy\n- Infective pneumonia\n- Pneumonitis due to inhaled substance\n- Tachycardia\n- Acquired hypothyroidism\n- Pleural effusion\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2012-03-30, presumably until 2012-03-30\n- polysaccharide iron complex, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous gluconate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous fumarate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous ascorbate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- iron,peptonized, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous succinate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous bisglycinate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous cysteine glycinate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- gabapentin 50 MG/ML Oral Solution, through Oral route, started on 2012-03-31, presumably until 2013-04-01, with intended 3 refill(s). Instructions: take 8 mL by mouth 3 times a day.\n- clonazepam 0.25 MG Disintegrating Oral Tablet, through Oral route, started on 2012-03-30, presumably until 2012-04-01\n- ferrous aspartate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2012-03-30, presumably until 2012-03-31\n- ammonium ferrous sulfate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- lacosamide 200 MG Oral Tablet, through Oral route, started on 2012-03-30, presumably until 2012-04-01\n- soy protein-iron complex, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2012-04-01, presumably until 2013-04-01, with intended 5 refill(s). Instructions: take 25 mL by mouth 2 times a day. Hold for more than 3 bowel movements per day.\n- ferrous carbonate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous glycine sulfate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- diatrizoate, through Oral route, started on 2012-03-31, presumably until 2012-03-31\n- lacosamide 10 MG/ML Oral Solution, through Oral route, started on 2012-04-01, presumably until 2012-04-01, with intended 3 refill(s). Instructions: take 200 mg by mouth 2 times a day.\n- iron succinyl milk protein complex, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- iron-dextran complex, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- prednisone 1 MG/ML Oral Solution, through Oral route, started on 2012-03-31, presumably until 2012-03-31\n- teferrol, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous asparto glycinate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous cacodylate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- diatrizoic acid, through Oral route, started on 2012-03-31, presumably until 2012-03-31\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2012-03-30, presumably until 2012-04-01\n- valproic acid 50 MG/ML Oral Solution, through Oral route, started on 2012-03-31, presumably until 2013-04-01, with intended 3 refill(s). Instructions: take 20 mL by mouth every bedtime.\n- iron, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous oxalate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2012-03-30, presumably until 2012-04-01\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-04-01, presumably until 2012-04-01\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2012-03-30, presumably until 2012-03-30\n- iron sucrose, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous sulfate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- iron carbonyl, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous lactate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous chloride, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- calcium carbonate 250 MG/ML Oral Suspension, through Oral route, started on 2012-03-31, presumably until 2013-04-01, with intended 5 refill(s). Instructions: 5 mL by Azul Swain route 2 times a day with meals.\n- levothyroxine sodium 0.075 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-04-01\n- 150 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2012-03-30, presumably until 2012-03-30\n- iron sorbitex, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous phosphate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2012-04-01, presumably until 2012-06-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-05-31 09:32:00, ended at 2012-05-31 12:53:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Change of gastrostomy tube, percutaneous, without imaging or endoscopic guidance\n- Attention to gastrostomy\n- Radiologic examination, abdomen; single anteroposterior view\n\n### Condition\n- Acquired hypothyroidism\n- Stoma malfunction\n- Developmental delay\n- Cerebral palsy\n- Constipation\n- Disorder of vertebral column\n- Mechanical complication of gastrostomy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-05 10:24:00, ended at 2012-06-05 15:09:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 1.5\" (inch (US))\n\n### Procedure\n- Replacement of gastrostomy or cecostomy (or other colonic) tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report\n- Change of gastrostomy tube\n\n### Condition\n- Cerebral palsy\n- Developmental delay\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-06-05, presumably until 2012-06-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-06-06 00:00:00, ended at 2012-06-06 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anemia\n\n### Drug\n- polysaccharide iron complex, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous gluconate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous fumarate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous ascorbate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron,peptonized, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous succinate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous bisglycinate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous cysteine glycinate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous aspartate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ammonium ferrous sulfate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- soy protein-iron complex, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous carbonate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous glycine sulfate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron succinyl milk protein complex, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron-dextran complex, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- teferrol, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous asparto glycinate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous cacodylate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous oxalate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron sucrose, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous sulfate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron carbonyl, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous lactate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous chloride, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron sorbitex, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous phosphate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-08-05 00:00:00, ended at 2012-08-05 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valproic acid 50 MG/ML Oral Solution, started on 2012-08-05, presumably until 2012-08-05, with intended 11 refill(s). Instructions: GIVE VIA G J-TUBE 15ML (750MG) TWICE DAILY AT 8AM & 4PM BEFORE MEALS  THEN 20ML (1000MG) AT 10PM.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Hyperlipidemia within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-02-16 00:00:00, ended at 2009-02-16 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 156 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.30 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.7 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Globulin [Mass/volume] in Serum: 5.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.88 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Valproate [Mass/volume] in Serum or Plasma: 110.1 (microgram per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.10 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.4 (femtoliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-11-02 23:01:00, ended at 2011-11-08 16:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 35 (millimole per liter)\n- Iron [Mass/volume] in Serum or Plasma: 30 (microgram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 481 (unit per liter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 13.8 (microgram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 21.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.5 (thousand per microliter)\n- Erythrocyte sedimentation rate: 134 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 159 (microgram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 45 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 149 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 3 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.08 (milli-international unit per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: >1000 (picogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 946 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.1 (percent)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 19 (percent)\n- MCV [Entitic volume] by Automated count: 97.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 2.4 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 9.0 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: Result checked (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.8 (nanogram per deciliter)\n- Valproate [Mass/volume] in Serum or Plasma: 33.1 (microgram per milliliter)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Monocytes/100 leukocytes in Blood by Manual count: 8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 330 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Globulin [Mass/volume] in Serum: 5.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 19 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.2 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 16.5 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n\n### Procedure\n- Prophylactic administration of vaccine against other diseases\n- Echocardiography\n- Molecular diagnostics; isolation or extraction of highly purified nucleic acid, each nucleic acid type (ie, DNA or RNA)\n- Molecular diagnostics; amplification, target, multiplex, first 2 nucleic acid sequences\n- Molecular diagnostics; reverse transcription\n- Molecular diagnostics; interpretation and report\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; subsequent\n- Radiologic examination, chest; single view, frontal\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Molecular diagnostics; amplification, target, multiplex, each additional nucleic acid sequence beyond 2 (List separately in addition to code for primary procedure)\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Molecular diagnostics; separation by gel electrophoresis (eg, agarose, polyacrylamide), each nucleic acid preparation\n- Radiologic examination, chest, special views (eg, lateral decubitus, Bucky studies)\n- Collection of venous blood by venipuncture\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; initial demonstration and/or evaluation\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Essential hypertension\n- Seizure disorder\n- Disorder of pericardium\n- Cardiomegaly\n- Fever\n- Acute renal failure syndrome\n- Leukocytosis\n- Physiological development failure\n- Pleural effusion\n- Atelectasis\n- Acquired hypothyroidism\n- Disorder of magnesium metabolism\n- Iron deficiency anemia\n- Cerebral palsy\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2011-11-05, presumably until 2011-11-08\n- divalproex sodium 250 MG Delayed Release Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- atenolol 50 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-07\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- sodium chloride 100 MG/ML Inhalation Solution, through Inhalation, started on 2011-11-05, presumably until 2011-11-08\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-07\n- miconazole nitrate 0.02 MG/MG Topical Ointment, through Topical route, started on 2011-11-06, presumably until 2011-11-08\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-11-03, presumably until 2011-11-05\n- gabapentin 400 MG Oral Capsule, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2011-11-03, presumably until 2011-11-08\n- lacosamide 100 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n- calcium carbonate 1250 MG Oral Tablet, through Oral route, started on 2011-11-03, presumably until 2011-11-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-12 13:34:00, ended at 2011-11-12 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Fever\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-11-15 00:00:00, ended at 2011-11-15 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Fever\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2011-11-16 07:24:00, ended at 2011-12-08 10:30:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.54 (million per microliter)\n- Globulin [Mass/volume] in Serum: 6.2 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 299 (unit per liter)\n- MCH [Entitic mass] by Automated count: 33.2 (picogram)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 2.27 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 678 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Valproate [Mass/volume] in Serum or Plasma: 50.6 (microgram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 0.99 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 3.9 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 22.6 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Body height: 5' 2\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 3.13 (thousand per microliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 1.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 21 (percent)\n- Monocytes/100 leukocytes in Blood by Manual count: 3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 308 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 38.6 (second)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 17.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 67 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Prothrombin time (PT): 15.4 (second)\n- Reticulocytes [#/volume] in Blood by Automated count: 47.9 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: <5 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 134 (millimeter per hour)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.3 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: <1 (nanogram per milliliter)\n- MCV [Entitic volume] by Automated count: 95.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.02 (thousand per microliter)\n\n### Procedure\n- Counseling\n- Pericardiocentesis\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Other incision of pleura\n- Molecular diagnostics; enzymatic digestion, each enzyme treatment\n- Computed tomographic angiography, neck, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Echocardiography\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Molecular diagnostics; separation by gel electrophoresis (eg, agarose, polyacrylamide), each nucleic acid preparation\n- Tube thoracostomy, includes connection to drainage system (eg, water seal), when performed, open (separate procedure)\n- Pericardiocentesis; initial\n- Molecular diagnostics; interpretation and report\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Replacement of gastrostomy or cecostomy (or other colonic) tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Radiologic examination, swallowing function, with cineradiography/videoradiography, including scout neck radiograph(s) and delayed image(s), when performed, contrast (eg, barium) study\n- Motion fluoroscopic evaluation of swallowing function by cine or video recording\n- Molecular diagnostics; mutation identification by sequencing, single segment, each segment\n- Biopsy of blood vessel\n- Collection of venous blood by venipuncture\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Occupational therapy evaluation\n- Molecular diagnostics; isolation or extraction of highly purified nucleic acid, each nucleic acid type (ie, DNA or RNA)\n- Evaluation of oral and pharyngeal swallowing function\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Radiologic examination, abdomen; single anteroposterior view\n- Arterial puncture, withdrawal of blood for diagnosis\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiological guidance (ie, fluoroscopy, ultrasound, or computed tomography), for percutaneous drainage (eg, abscess, specimen collection), with placement of catheter, radiological supervision and interpretation\n- Radiologic examination, chest; single view, frontal\n- Packed blood cell transfusion\n\n### Condition\n- Cerebral palsy\n- Disorder of magnesium metabolism\n- Primary malignant neoplasm of colon\n- Disorder of lung\n- Familial Mediterranean fever\n- Temporal arteritis\n- Lung field abnormal\n- Physiological development failure\n- Cardiac arrhythmia\n- Disorder of pericardium\n- Osteoporosis\n- Anemia\n- Leukocytosis\n- Acute renal failure syndrome\n- Hypoxemia\n- Pleural effusion\n- Acquired hypothyroidism\n- Atelectasis\n- Atherosclerosis of aorta\n- Dysphagia\n- Dyspnea\n- Fever\n- Pneumonitis due to inhaled substance\n- Prostatitis\n- Second degree atrioventricular block\n- Acute idiopathic pericarditis\n- Epilepsy\n\n### Drug\n- gabapentin 50 MG/ML Oral Solution, through Oral route, started on 2011-11-19, presumably until 2011-12-06\n- atenolol 50 MG Oral Tablet, through Oral route, started on 2011-12-07, presumably until 2012-01-08, with intended 0 refill(s). Instructions: take 50 mg by mouth daily. Hold for systolic BP below 100, and if heartrate is below 60 BPM \n- methylprednisolone 40 MG Injection, started on 2011-11-27, presumably until 2011-11-30\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-12-07. Instructions: 10 mg by Other route every bedtime. Given Via G-J Tube.\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2011-11-25, presumably until 2011-12-08\n- potassium phosphate, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- tribasic potassium phosphate, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2011-11-21, presumably until 2011-12-01\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2011-11-19, presumably until 2011-11-29\n- lacosamide 200 MG Oral Tablet, through Oral route, started on 2011-11-30, presumably until 2012-04-01. Instructions: 200 mg by Other route 2 times a day. Given via G-J tube\n- alendronic acid 70 MG Oral Tablet, presumably until 2012-06-05. Instructions: 70 mg by Other route once a week. Every Friday Given via G-J tube\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2011-11-25, presumably until 2011-12-08\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-12-08. Instructions: take by mouth 2 times a day.\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-11-17, presumably until 2011-11-17\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2011-12-03, presumably until 2011-12-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- ibuprofen 400 MG Oral Tablet, through Oral route, started on 2011-11-30, presumably until 2011-11-30\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-11-17, presumably until 2011-12-08\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2011-11-19, presumably until 2011-11-19\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2011-11-19, presumably until 2011-11-30\n- tribasic sodium phosphate, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2011-11-22, presumably until 2011-11-22\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-26. Instructions: take by mouth daily.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-11-16, presumably until 2012-04-01. Instructions: 250 mg by Other route daily. Given via G-J tube.\n- gabapentin 400 MG Oral Capsule, through Oral route, started on 2011-11-16, presumably until 2012-04-01, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day.\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2011-11-30, presumably until 2011-12-08. Instructions: take by mouth daily.\n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2011-11-30, presumably until 2011-12-08. Instructions: take by mouth daily.\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2011-11-17, presumably until 2011-11-30\n- colchicine 0.6 MG Oral Tablet, through Oral route, started on 2011-11-29, presumably until 2012-01-08, with intended 5 refill(s). Instructions: take 1 Tab by mouth daily.\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2011-12-03, presumably until 2011-12-08, with intended 0 refill(s). Instructions: take 3 Tabs by mouth daily.\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2011-11-20, presumably until 2011-11-24\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2011-11-17, presumably until 2011-11-29\n- lacosamide 100 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-17\n- valproic acid 50 MG/ML Oral Solution, through Oral route, started on 2011-11-30, presumably until 2012-01-08, with intended 5 refill(s). Instructions: take 15 mL by mouth every morning.\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2011-11-16, presumably until 2011-11-16\n- sodium phosphate, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- sodium phosphate, monobasic, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- 2 ML ondansetron 2 MG/ML Injection, started on 2011-11-17, presumably until 2011-11-19\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2011-11-16, presumably until 2011-11-16\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-11-17, presumably until 2011-11-21\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2011-11-30, presumably until 2011-11-30\n- sodium phosphate, dibasic, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- lamotrigine 25 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-22. Instructions: take 25 mg by mouth every other day.\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2011-11-30, presumably until 2011-12-08\n- 2 ML diazepam 5 MG/ML Auto-Injector, started on 2011-11-24, presumably until 2011-12-01\n- divalproex sodium 500 MG Delayed Release Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-17. Instructions: take 500 mg by mouth 2 times a day.\n- nystatin 100 UNT/MG Topical Powder, through Topical route, started on 2011-12-05, presumably until 2011-12-05\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2011-11-23, presumably until 2011-11-29\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2011-12-01, presumably until 2011-12-02\n- calcium carbonate 1250 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2012-02-25. Instructions: take 1 Tab by mouth daily. 500 mg 3 times a day \n- dibasic sodium phosphate heptahydrate, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2011-12-03, presumably until 2012-01-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth Q12H.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-11-21, presumably until 2011-12-02\n- dibasic potassium phosphate, through Oral route, started on 2011-11-25, presumably until 2011-11-25\n- albuterol 0.83 MG/ML Inhalation Solution, through Inhalation, started on 2011-11-29, presumably until 2011-12-04\n- 1 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-11-16, presumably until 2011-11-16\n- 300 ML linezolid 2 MG/ML Injection, through Intravenous route, started on 2011-11-17, presumably until 2011-11-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-11-16 08:39:08, ended at 2011-11-16 12:45:17\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Disorder of pericardium\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-20 10:20:21, ended at 2011-11-20 16:50:18\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Disorder of pericardium\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-11-30 08:06:54, ended at 2011-11-30 14:56:55\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Disorder of pericardium\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-12-06 15:05:29, ended at 2011-12-06 15:35:19\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Disorder of pericardium\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-12-14 00:00:00, ended at 2011-12-14 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Prostatitis\n- Epilepsy\n- Anemia\n- Leukocytosis\n- Cerebral palsy\n\n### Drug\n- polyethylene glycol 3350 420000 MG / potassium chloride 1480 MG / sodium bicarbonate 5720 MG / sodium chloride 11200 MG Powder for Oral Solution, through Oral route, started on 2011-12-14, presumably until 2012-02-25, with intended 0 refill(s). Instructions: take 420 g by mouth as directed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2011-12-16 19:06:00, ended at 2012-01-08 13:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Base excess in Blood by calculation: 1.0 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.27 (millimole per liter)\n- Iron [Mass/volume] in Serum or Plasma: 55 (microgram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 161 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Manual count: 9 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 42 (percent)\n- Thrombin time: 16.3 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.9 (microgram per milliliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 21 (percent)\n- MCHC [Mass/volume] by Automated count: 36.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Prolactin [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Body height: 5' 4.016\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythropoietin (EPO) [Units/volume] in Serum or Plasma: 128 (milliunit per milliliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1430 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.07 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.86 (thousand per microliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: <5 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Erythrocyte sedimentation rate: 99 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 5.7 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 44 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- MCH [Entitic mass] by Automated count: 35.0 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 28.4 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 1.06 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 29.5 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- MCV [Entitic volume] by Automated count: 97.3 (femtoliter)\n- Osmolality of Serum or Plasma: 327 (milliosmole per kilogram)\n- Prothrombin time (PT): N/A (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.42 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 125 (microgram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.7 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 15.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.5 (percent)\n- Osmolality of Urine: 360 (milliosmole per kilogram)\n- Sodium [Moles/volume] in Serum or Plasma: 155 (millimole per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: N/A (nanogram per deciliter)\n- Valproate [Mass/volume] in Serum or Plasma: 69.6 (microgram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.7 (second)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 3.60 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 490 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.94 (milli-international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 661 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n\n### Procedure\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; initial demonstration and/or evaluation\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Insertion of endotracheal tube\n- Radiologic examination, swallowing function, with cineradiography/videoradiography, including scout neck radiograph(s) and delayed image(s), when performed, contrast (eg, barium) study\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Echocardiography\n- Radiologic examination, abdomen; single anteroposterior view\n- Physical therapy evaluation\n- Conversion of gastrostomy tube to gastro-jejunostomy tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report\n- Packed blood cell transfusion\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Radiologic examination, chest; single view, frontal\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Controlled ventilation procedure and therapy, initiation and management\n- Occupational therapy evaluation\n- Central venous catheter placement with guidance\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Percutaneous [endoscopic] gastrojejunostomy\n- Collection of venous blood by venipuncture\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Counseling\n- Other incision of pleura\n- Continuous invasive mechanical ventilation for less than 96 consecutive hours\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Insertion of gastrostomy tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Therapeutic procedure, 1 or more areas, each 15 minutes; neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Evaluation of oral and pharyngeal swallowing function\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Endoscopic polypectomy of large intestine\n- Motion fluoroscopic evaluation of swallowing function by cine or video recording\n\n### Condition\n- Atelectasis\n- Disorder of pericardium\n- Neoplasm of uncertain behavior of digestive organ\n- Acquired hypothyroidism\n- Hyperosmolality and or hypernatremia\n- Lymphadenopathy\n- Pleural effusion\n- Severe sepsis\n- Sepsis\n- Septic shock\n- Pain in limb\n- Acute renal failure syndrome\n- Anemia\n- Dysphagia\n- Fever\n- Pneumonitis due to inhaled substance\n- Thoracic spondylosis without myelopathy\n- Acute posthemorrhagic anemia\n- Benign neoplasm of colon\n- Cerebral palsy\n- Diarrhea\n- Epilepsy\n- Hypoxemia\n- Leukocytosis\n- Physiological development failure\n- Disorder of magnesium metabolism\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-12-24, presumably until 2012-01-04\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2011-12-26, presumably until 2011-12-28\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2011-12-24, presumably until 2011-12-25\n- clonazepam 0.25 MG Disintegrating Oral Tablet, through Oral route, started on 2012-01-04, presumably until 2012-02-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- 50 ML famotidine 0.4 MG/ML Injection, through Intravenous route, started on 2011-12-19, presumably until 2011-12-21\n- acetaminophen 650 MG Rectal Suppository, through Rectal route, started on 2011-12-29, presumably until 2013-01-07, with intended 1 refill(s). Instructions: insert 1 Suppository into the rectum every 4 hours as needed for Fever.\n- methylprednisolone 40 MG Injection, started on 2011-12-24, presumably until 2012-01-04\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2011-12-28. Instructions: take 10 mg by mouth every bedtime.\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2011-12-17, presumably until 2011-12-21\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2012-01-01, presumably until 2012-01-02\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-01-04, presumably until 2012-01-06\n- lacosamide 200 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2011-12-17. Instructions: take 200 mg by mouth 2 times a day.\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-12-19, presumably until 2011-12-21\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2011-12-27, presumably until 2011-12-28\n- divalproex sodium 125 MG Delayed Release Oral Capsule, through Oral route, started on 2011-12-24, presumably until 2011-12-28\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2011-12-22, presumably until 2011-12-28\n- nystatin 100000 UNT/ML Topical Cream, through Topical route, started on 2011-12-18, presumably until 2012-01-08\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2012-01-01, presumably until 2012-01-04\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2011-12-28\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2011-12-25, presumably until 2012-02-25, with intended 1 refill(s). Instructions: take 3 Tabs by mouth daily. Take 3 tabs per day until 12/20.  On 01/16/2012, start taking 2 tabs per day.  On 01/29/2012, start taking 1 tab per day and continue at this dosage until your appointment with rheumatology.\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-12-24, presumably until 2012-01-02\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2011-12-20, presumably until 2011-12-20\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2011-12-17, presumably until 2012-01-02\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2011-12-29, presumably until 2011-12-29\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2012-01-06, presumably until 2012-02-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Take for another 4 days.\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-12-19, presumably until 2011-12-27\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2011-12-27. Instructions: take by mouth daily.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-12-19, presumably until 2011-12-19. Instructions: take 250 mg by mouth daily.\n- gabapentin 400 MG Oral Capsule, through Oral route, started on 2011-12-17, presumably until 2012-01-08. Instructions: take 400 mg by mouth 3 times a day.\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2011-12-28, presumably until 2011-12-28. Instructions: take by mouth daily.\n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2011-12-28, presumably until 2011-12-28. Instructions: take by mouth daily.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2011-12-17, presumably until 2011-12-24\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2011-12-17, presumably until 2011-12-29\n- colchicine 0.6 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2011-12-28. Instructions: take 1 Tab by mouth daily.\n- ipratropium bromide 0.2 MG/ML Inhalation Solution, through Inhalation, started on 2011-12-29, presumably until 2012-01-05\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2011-12-22, presumably until 2012-01-07\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2011-12-16, presumably until 2011-12-21\n- lacosamide 100 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2012-01-08. Instructions: take 200 mg by mouth 2 times a day.\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2011-12-18, presumably until 2011-12-26\n- valproic acid 50 MG/ML Oral Solution, through Oral route, started on 2011-12-17, presumably until 2012-02-25, with intended 1 refill(s). Instructions: take 20 mL by mouth daily in the evening. Administer via G-tube at 10PM every day.\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2011-12-16, presumably until 2012-01-04\n- clindamycin 300 MG Oral Capsule, through Oral route, started on 2012-01-06, presumably until 2012-02-25, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day. Take for 4 days.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection, through Intravenous route, started on 2011-12-30, presumably until 2011-12-30\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-12-26, presumably until 2011-12-30\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2011-12-16, presumably until 2012-01-03\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-12-29, presumably until 2012-01-03\n- prednisone 50 MG Oral Tablet, through Oral route, started on 2011-12-25, presumably until 2011-12-26\n- levothyroxine sodium 0.075 MG Oral Tablet, through Oral route, started on 2012-01-08, presumably until 2012-02-25, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily.\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2011-12-20, presumably until 2011-12-20\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2011-12-28, presumably until 2012-01-08\n- calcium carbonate 1250 MG Oral Tablet, through Oral route, started on 2011-12-17, presumably until 2011-12-28. Instructions: take 1 Tab by mouth daily. 500 mg 3 times a day \n- midazolam 1 MG/ML Injectable Solution, started on 2011-12-20, presumably until 2011-12-20\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2012-01-04, presumably until 2012-01-06\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2012-01-03, presumably until 2012-01-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-02-25 15:55:00, ended at 2012-02-26 19:17:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 109 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Valproate [Mass/volume] in Serum or Plasma: 54.1 (microgram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Attention to gastrostomy\n- Change of gastrostomy tube, percutaneous, without imaging or endoscopic guidance\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordinat\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Replacement of gastro-jejunostomy tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report\n\n### Condition\n- Seizure\n- Stoma malfunction\n- Physiological development failure\n- Cerebral palsy\n- Epilepsy\n- Mechanical complication of gastrostomy\n- Clinical finding\n\n### Drug\n- polysaccharide iron complex, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous gluconate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous fumarate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous ascorbate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- iron,peptonized, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous succinate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous bisglycinate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous cysteine glycinate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous aspartate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ammonium ferrous sulfate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2012-02-26, presumably until 2012-02-26\n- soy protein-iron complex, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous carbonate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous glycine sulfate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- iron succinyl milk protein complex, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- iron-dextran complex, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- teferrol, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous asparto glycinate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous cacodylate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- valproic acid 50 MG/ML Oral Solution, through Oral route, started on 2012-02-26, presumably until 2012-02-26\n- iron, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous oxalate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-02-25, presumably until 2012-02-25\n- iron sucrose, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous sulfate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- iron carbonyl, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous lactate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous chloride, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- levothyroxine sodium 0.075 MG Oral Tablet. Instructions: 75 mcg by Other route daily. Given via G-J tube. \n- iron sorbitex, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n- ferrous phosphate, through Oral route, presumably until 2012-04-01. Instructions: take 15 mL by mouth.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2012-03-30 15:33:00, ended at 2012-04-01 17:13:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Base deficit in Blood: 4.0 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 36.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.75 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Blood by calculation: 2.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bicarbonate [Moles/volume] in Specimen: 20.5 (milliequivalent per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 38.0 (picogram)\n- MCV [Entitic volume] by Automated count: 104.9 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 7.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 27 (percent)\n- Platelets [#/volume] in Blood by Automated count: 74 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Body height: 5' 4\" (inch (US))\n- Globulin [Mass/volume] in Serum: 5.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.77 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 27.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 17.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 51 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Oxygen [Partial pressure] in Blood: 36 (millimeter mercury column)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Carbon dioxide [Partial pressure] in Blood: 34.2 (millimeter mercury column)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.6 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Change of gastrostomy tube\n- Insertion of non-indwelling bladder catheter (eg, straight catheterization for residual urine)\n- Radiologic examination, chest; single view, frontal\n- Radiologic examination, abdomen; single anteroposterior view\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Replacement of gastro-jejunostomy tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Fever\n- Cerebral palsy\n- Vomiting\n- Epilepsy\n- Infective pneumonia\n- Pneumonitis due to inhaled substance\n- Tachycardia\n- Acquired hypothyroidism\n- Pleural effusion\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2012-03-30, presumably until 2012-03-30\n- polysaccharide iron complex, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous gluconate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous fumarate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous ascorbate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- iron,peptonized, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous succinate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous bisglycinate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous cysteine glycinate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- gabapentin 50 MG/ML Oral Solution, through Oral route, started on 2012-03-31, presumably until 2013-04-01, with intended 3 refill(s). Instructions: take 8 mL by mouth 3 times a day.\n- clonazepam 0.25 MG Disintegrating Oral Tablet, through Oral route, started on 2012-03-30, presumably until 2012-04-01\n- ferrous aspartate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2012-03-30, presumably until 2012-03-31\n- ammonium ferrous sulfate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- lacosamide 200 MG Oral Tablet, through Oral route, started on 2012-03-30, presumably until 2012-04-01\n- soy protein-iron complex, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2012-04-01, presumably until 2013-04-01, with intended 5 refill(s). Instructions: take 25 mL by mouth 2 times a day. Hold for more than 3 bowel movements per day.\n- ferrous carbonate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous glycine sulfate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- diatrizoate, through Oral route, started on 2012-03-31, presumably until 2012-03-31\n- lacosamide 10 MG/ML Oral Solution, through Oral route, started on 2012-04-01, presumably until 2012-04-01, with intended 3 refill(s). Instructions: take 200 mg by mouth 2 times a day.\n- iron succinyl milk protein complex, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- iron-dextran complex, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- prednisone 1 MG/ML Oral Solution, through Oral route, started on 2012-03-31, presumably until 2012-03-31\n- teferrol, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous asparto glycinate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous cacodylate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- diatrizoic acid, through Oral route, started on 2012-03-31, presumably until 2012-03-31\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2012-03-30, presumably until 2012-04-01\n- valproic acid 50 MG/ML Oral Solution, through Oral route, started on 2012-03-31, presumably until 2013-04-01, with intended 3 refill(s). Instructions: take 20 mL by mouth every bedtime.\n- iron, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous oxalate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2012-03-30, presumably until 2012-04-01\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-04-01, presumably until 2012-04-01\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2012-03-30, presumably until 2012-03-30\n- iron sucrose, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous sulfate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- iron carbonyl, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous lactate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous chloride, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- calcium carbonate 250 MG/ML Oral Suspension, through Oral route, started on 2012-03-31, presumably until 2013-04-01, with intended 5 refill(s). Instructions: 5 mL by Azul Swain route 2 times a day with meals.\n- levothyroxine sodium 0.075 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-04-01\n- 150 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2012-03-30, presumably until 2012-03-30\n- iron sorbitex, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- ferrous phosphate, through Oral route, started on 2012-04-01, presumably until 2012-06-06, with intended 3 refill(s). Instructions: take 15 mL by mouth Every Day.\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2012-04-01, presumably until 2012-06-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-05-31 09:32:00, ended at 2012-05-31 12:53:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Change of gastrostomy tube, percutaneous, without imaging or endoscopic guidance\n- Attention to gastrostomy\n- Radiologic examination, abdomen; single anteroposterior view\n\n### Condition\n- Acquired hypothyroidism\n- Stoma malfunction\n- Developmental delay\n- Cerebral palsy\n- Constipation\n- Disorder of vertebral column\n- Mechanical complication of gastrostomy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-05 10:24:00, ended at 2012-06-05 15:09:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 1.5\" (inch (US))\n\n### Procedure\n- Replacement of gastrostomy or cecostomy (or other colonic) tube, percutaneous, under fluoroscopic guidance including contrast injection(s), image documentation and report\n- Change of gastrostomy tube\n\n### Condition\n- Cerebral palsy\n- Developmental delay\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-06-05, presumably until 2012-06-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-06-06 00:00:00, ended at 2012-06-06 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anemia\n\n### Drug\n- polysaccharide iron complex, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous gluconate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous fumarate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous ascorbate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron,peptonized, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous succinate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous bisglycinate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous cysteine glycinate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous aspartate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ammonium ferrous sulfate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- soy protein-iron complex, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous carbonate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous glycine sulfate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron succinyl milk protein complex, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron-dextran complex, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- teferrol, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous asparto glycinate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous cacodylate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous oxalate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron sucrose, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous sulfate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron carbonyl, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous lactate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous chloride, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- iron sorbitex, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n- ferrous phosphate, started on 2012-06-06, presumably until 2012-06-06, with intended 10 refill(s). Instructions: GIVE 15ML VIA G-TUBE DAILY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-08-05 00:00:00, ended at 2012-08-05 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valproic acid 50 MG/ML Oral Solution, started on 2012-08-05, presumably until 2012-08-05, with intended 11 refill(s). Instructions: GIVE VIA G J-TUBE 15ML (750MG) TWICE DAILY AT 8AM & 4PM BEFORE MEALS  THEN 20ML (1000MG) AT 10PM.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Hyperlipidemia within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of hyperlipidemia means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "835aee01e92312e16f29194f3405735d2930ce89d234c70037c4634aff84fec5", "prompt_hash": "35ead0455ce86f8c1f9196d33f5b5deb547fc038e24d5f535990d0146f1a3cd1", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 9, "doc": {"person_id": 115968263, "visit_occurrence_id": 33366398, "death_date": null, "visit_concept_name": "Case Management Visit", "visit_start_datetime": "2009-07-02 00:00:00", "visit_end_datetime": "2009-07-02 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Case Management Visit, started at 2009-07-02 00:00:00, ended at 2009-07-02 00:00:00\nThe patient in this visit was 50 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Multiple myeloma\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 87, "patient_first_visit_date": "2008-03-14 00:00:00", "patient_last_visit_date": "2022-07-14 00:00:00", "end_obs_date": "2010-07-02", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 37, "cumulated_visit_num": 37, "cumulated_approximate_token_count": 19730, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-14 00:00:00, ended at 2008-03-14 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.56 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.6 (second)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 111 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 98.3 (femtoliter)\n- Prothrombin time (PT): 15.2 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-15 00:00:00, ended at 2008-03-15 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- MCH [Entitic mass] by Automated count: 33.9 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.02 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.2 (percent)\n- MCV [Entitic volume] by Automated count: 98.9 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.36 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.04 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 124 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-16 00:00:00, ended at 2008-03-16 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.91 (million per microliter)\n- MCV [Entitic volume] by Automated count: 97.5 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 112 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 166 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.9 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-03-18 12:23:00, ended at 2008-03-18 23:59:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 38 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 17.2 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.8 (percent)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.11 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Multiple myeloma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-27 00:00:00, ended at 2008-03-27 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.59 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.18 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 40 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.20 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.1 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-10 00:00:00, ended at 2008-04-10 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.01 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 53 (percent)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 11 (percent)\n- Platelets [#/volume] in Blood by Automated count: 380 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Manual count: 2.1 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.2 (percent)\n- MCV [Entitic volume] by Automated count: 97.1 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 18 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.6 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Manual count: 3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-11 00:00:00, ended at 2008-04-11 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-12 00:00:00, ended at 2008-04-12 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 34.2 (picogram)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.74 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.1 (percent)\n- MCV [Entitic volume] by Automated count: 98.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 298 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-04-22 18:45:00, ended at 2008-04-23 02:30:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 20.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.66 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 18.48 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 96 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 101 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.6 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.27 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.1 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neutropenic disorder\n- Abnormal body temperature\n- Benign prostatic hyperplasia without outflow obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-24 00:00:00, ended at 2008-04-24 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 142 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.50 (million per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 28.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 26 (percent)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.21 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Leukocytes [#/volume] in Specimen by Automated count: 31.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 1 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 2.2 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-25 00:00:00, ended at 2008-04-25 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.6 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.30 (million per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 125 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 33.0 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-26 00:00:00, ended at 2008-04-26 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.5 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.25 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 121 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 95.4 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 39.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.33 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-05 00:00:00, ended at 2008-05-05 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 176 (unit per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 52 (percent)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.7 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Manual count: 2.0 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Manual count: 0.0 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.9 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 24 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-08 00:00:00, ended at 2008-05-08 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Monocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.4 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.96 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 177 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 201 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- MCV [Entitic volume] by Automated count: 94.5 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 22.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.6 (percent)\n- Prothrombin time (PT): 15.3 (second)\n- Neutrophils [#/volume] in Blood by Automated count: 2.02 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-10 00:00:00, ended at 2008-05-10 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Manual count: 1.9 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 0.4 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils [#/volume] in Blood by Manual count: 0.0 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.06 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.6 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Manual count: 13 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 58 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 20 (percent)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.54 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 141 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-11 00:00:00, ended at 2008-05-11 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.58 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.7 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.8 (percent)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 133 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-12 00:00:00, ended at 2008-05-12 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.80 (million per microliter)\n- MCV [Entitic volume] by Automated count: 94.1 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.9 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 114 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.2 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.67 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-13 00:00:00, ended at 2008-05-13 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 19.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.06 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.3 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 106 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.50 (million per microliter)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 134 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-14 00:00:00, ended at 2008-05-14 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.94 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.6 (percent)\n- MCV [Entitic volume] by Automated count: 97.0 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.6 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 86 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.47 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-05-15 14:00:00, ended at 2008-05-15 23:59:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.5 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 56 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.8 (percent)\n- MCV [Entitic volume] by Automated count: 94.5 (femtoliter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-16 00:00:00, ended at 2008-05-16 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.31 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 35 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.9 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.7 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.8 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.1 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-05-17 11:30:00, ended at 2008-05-17 23:59:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: Not avail (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 0.4 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.25 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 22 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-05-18 09:30:00, ended at 2008-05-18 16:06:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 9 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 0.2 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.01 (million per microliter)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: Not avail (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-05-18 16:07:00, ended at 2008-05-27 18:15:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 39.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 78 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Body height: 5' 7\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.38 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 2.31 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.35 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: Not avail (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Imaging of thorax abnormal\n\n### Drug\n- glycerin, through Topical route, started on 2008-05-20, presumably until 2008-05-20\n- hydrocortisone 100 MG Injection, started on 2008-05-24, presumably until 2008-05-24\n- 72 HR fentanyl 0.025 MG/HR Transdermal System, through Transdermal route, started on 2008-05-24, presumably until 2008-05-24\n- 0.5 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2008-05-19, presumably until 2008-05-23\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-05-18, presumably until 2008-05-27\n- water, through Topical route, started on 2008-05-20, presumably until 2008-05-20\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2008-05-18, presumably until 2008-05-27\n- codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2008-05-22, presumably until 2008-05-22\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2008-05-23, presumably until 2008-05-24\n- dimethicone, through Topical route, started on 2008-05-20, presumably until 2008-05-20\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2008-05-27, presumably until 2014-05-19, with quantity of 60.0, with intended 5 refill(s). Instructions: take 400 mg by mouth 3 times a day. \n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2008-05-27, presumably until 2008-05-27\n- bisacodyl 5 MG Delayed Release Oral Tablet, through Oral route, started on 2008-05-25, presumably until 2008-05-25\n- voriconazole 200 MG Injection, through Intravenous route, started on 2008-05-23, presumably until 2008-05-27\n- diphenhydramine hydrochloride 2.5 MG/ML Oral Solution, through Oral route, started on 2008-05-19, presumably until 2008-05-20\n- heparin sodium, porcine 100 UNT/ML Injectable Solution, through Intravenous route, started on 2008-05-27, presumably until 2008-05-27\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2008-05-18, presumably until 2008-05-25\n- 1 ML meperidine hydrochloride 25 MG/ML Cartridge, started on 2008-05-24, presumably until 2008-05-24\n- lorazepam 1 MG Oral Tablet, through Oral route. Instructions: take 1 mg by mouth every 4 hours as needed \n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2008-05-18, presumably until 2008-05-24. Instructions: take 500 mg by mouth 2 times a day. \n- clotrimazole 10 MG Oral Lozenge, through Submucosal route, started on 2008-05-18, presumably until 2008-05-25. Instructions: by Mucous Membrane route 4 times a day. \n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2008-05-24, presumably until 2008-05-27\n- voriconazole 200 MG Oral Tablet, through Oral route, started on 2008-05-27, presumably until 2009-05-27, with quantity of 60.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- azithromycin 500 MG Oral Tablet, through Oral route, started on 2008-05-28, presumably until 2009-06-06, with quantity of 10.0, with intended 0 refill(s). Instructions: take 500 mg by mouth daily. \n- soybean oil 100 MG/ML Injectable Suspension, through Intravenous route, started on 2008-05-21, presumably until 2008-05-23\n- cefepime 2000 MG Injection, through Intravenous route, started on 2008-05-18, presumably until 2008-05-20\n- 50 ML immunoglobulin G, human 100 MG/ML Injection, through Intravenous route, started on 2008-05-23, presumably until 2008-05-23\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2008-05-18, presumably until 2008-05-24\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2008-05-19, presumably until 2008-05-20\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2008-05-21, presumably until 2008-05-21\n- 250 ML heparin sodium, porcine 100 UNT/ML Injection, through Intravenous route, started on 2008-05-18, presumably until 2008-05-23\n- 100 ML potassium chloride 0.2 MEQ/ML Injection, through Intravenous route, started on 2008-05-19, presumably until 2008-05-25\n- 72 HR scopolamine 0.0139 MG/HR Transdermal System, through Transdermal route, started on 2008-05-19, presumably until 2008-05-19\n- 72 HR fentanyl 0.05 MG/HR Transdermal System, through Transdermal route, started on 2008-05-21, presumably until 2008-05-21\n- petrolatum, through Topical route, started on 2008-05-20, presumably until 2008-05-20\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2008-05-19, presumably until 2008-05-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-05-29 13:30:00, ended at 2008-05-29 23:59:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 191 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.0 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.88 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-05-31 10:00:00, ended at 2008-05-31 23:59:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.90 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 45 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.2 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Basophils [#/volume] in Blood by Manual count: 0.0 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.91 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- MCV [Entitic volume] by Automated count: 93.4 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.2 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 39 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 1.7 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-05 00:00:00, ended at 2008-06-05 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.98 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 27.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 205 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.38 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.08 (million per microliter)\n- MCV [Entitic volume] by Automated count: 94.5 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.87 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-09 00:00:00, ended at 2008-06-09 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.01 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.6 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 54 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 10 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Manual count: 3.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- Monocytes [#/volume] in Blood by Manual count: 1.8 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 137 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 33 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-21 00:00:00, ended at 2008-06-21 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.06 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.10 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.17 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 170 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.8 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-03 00:00:00, ended at 2008-07-03 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.03 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.6 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- MCH [Entitic mass] by Automated count: 34.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 145 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 100.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 184 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.16 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.78 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-14 00:00:00, ended at 2008-07-14 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.1 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.37 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 191 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 101.5 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-20 00:00:00, ended at 2008-07-20 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.73 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.86 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.6 (percent)\n- MCH [Entitic mass] by Automated count: 35.5 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 102.0 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 195 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-28 00:00:00, ended at 2008-07-28 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.7 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.96 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.63 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- MCV [Entitic volume] by Automated count: 102.9 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 238 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-08-03 00:00:00, ended at 2008-08-03 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 214 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.20 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 102.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.93 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.6 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.7 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-08-16 00:00:00, ended at 2008-08-16 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 104.0 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.27 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 36.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.1 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.74 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 196 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-09-04 11:30:00, ended at 2008-09-04 23:59:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- CD3 cells [#/volume] in Blood: 219 (per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- CD19 cells [#/volume] in Blood: 129 (per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.93 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 101.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 168 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.6 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.9 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- CD3 cells/100 cells in Blood: 46 (percent)\n- CD3+CD4+ (T4 helper) cells [#/volume] in Blood: 95 (per microliter)\n- CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood: 196 (per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- CD19 cells/100 cells in Blood: 27 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.90 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-07-02 00:00:00, ended at 2009-07-02 00:00:00\nThe patient in this visit was 50 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Multiple myeloma\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive their first ever diagnosis of Hyperlipidemia within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-14 00:00:00, ended at 2008-03-14 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.56 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.6 (second)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 111 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 98.3 (femtoliter)\n- Prothrombin time (PT): 15.2 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-15 00:00:00, ended at 2008-03-15 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- MCH [Entitic mass] by Automated count: 33.9 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.02 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.2 (percent)\n- MCV [Entitic volume] by Automated count: 98.9 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.36 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.04 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 124 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-16 00:00:00, ended at 2008-03-16 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.91 (million per microliter)\n- MCV [Entitic volume] by Automated count: 97.5 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 112 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 166 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.9 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-03-18 12:23:00, ended at 2008-03-18 23:59:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 38 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 17.2 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.8 (percent)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.11 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Multiple myeloma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-27 00:00:00, ended at 2008-03-27 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.59 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.18 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 40 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.20 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.1 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-10 00:00:00, ended at 2008-04-10 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.01 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 53 (percent)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 11 (percent)\n- Platelets [#/volume] in Blood by Automated count: 380 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Manual count: 2.1 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.2 (percent)\n- MCV [Entitic volume] by Automated count: 97.1 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 18 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.6 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Manual count: 3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-11 00:00:00, ended at 2008-04-11 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-12 00:00:00, ended at 2008-04-12 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 34.2 (picogram)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.74 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.1 (percent)\n- MCV [Entitic volume] by Automated count: 98.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 298 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-04-22 18:45:00, ended at 2008-04-23 02:30:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 20.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.66 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 18.48 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 96 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 101 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.6 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.27 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.1 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neutropenic disorder\n- Abnormal body temperature\n- Benign prostatic hyperplasia without outflow obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-24 00:00:00, ended at 2008-04-24 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 142 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.50 (million per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 28.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 26 (percent)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.21 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Leukocytes [#/volume] in Specimen by Automated count: 31.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 1 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 2.2 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-25 00:00:00, ended at 2008-04-25 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.6 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.30 (million per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 125 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 33.0 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-26 00:00:00, ended at 2008-04-26 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.5 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.25 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 121 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 95.4 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 39.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.33 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-05 00:00:00, ended at 2008-05-05 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 176 (unit per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 52 (percent)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.7 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Manual count: 2.0 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Manual count: 0.0 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.9 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 24 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-08 00:00:00, ended at 2008-05-08 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Monocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.4 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.96 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 177 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 201 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- MCV [Entitic volume] by Automated count: 94.5 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 22.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.6 (percent)\n- Prothrombin time (PT): 15.3 (second)\n- Neutrophils [#/volume] in Blood by Automated count: 2.02 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-10 00:00:00, ended at 2008-05-10 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Manual count: 1.9 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 0.4 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils [#/volume] in Blood by Manual count: 0.0 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.06 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.6 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Manual count: 13 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 58 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 20 (percent)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.54 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 141 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-11 00:00:00, ended at 2008-05-11 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.58 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.7 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.8 (percent)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 133 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-12 00:00:00, ended at 2008-05-12 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.80 (million per microliter)\n- MCV [Entitic volume] by Automated count: 94.1 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.9 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 114 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.2 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.67 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-13 00:00:00, ended at 2008-05-13 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 19.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.06 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.3 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 106 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.50 (million per microliter)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 134 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-14 00:00:00, ended at 2008-05-14 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.94 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.6 (percent)\n- MCV [Entitic volume] by Automated count: 97.0 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.6 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 86 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.47 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-05-15 14:00:00, ended at 2008-05-15 23:59:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.5 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 56 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.8 (percent)\n- MCV [Entitic volume] by Automated count: 94.5 (femtoliter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-16 00:00:00, ended at 2008-05-16 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.31 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 35 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.9 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.7 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.8 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.1 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-05-17 11:30:00, ended at 2008-05-17 23:59:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: Not avail (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 0.4 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.25 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 22 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-05-18 09:30:00, ended at 2008-05-18 16:06:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 9 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 0.2 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.01 (million per microliter)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: Not avail (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-05-18 16:07:00, ended at 2008-05-27 18:15:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 39.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 78 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Body height: 5' 7\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.38 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 2.31 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.35 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: Not avail (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Imaging of thorax abnormal\n\n### Drug\n- glycerin, through Topical route, started on 2008-05-20, presumably until 2008-05-20\n- hydrocortisone 100 MG Injection, started on 2008-05-24, presumably until 2008-05-24\n- 72 HR fentanyl 0.025 MG/HR Transdermal System, through Transdermal route, started on 2008-05-24, presumably until 2008-05-24\n- 0.5 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2008-05-19, presumably until 2008-05-23\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-05-18, presumably until 2008-05-27\n- water, through Topical route, started on 2008-05-20, presumably until 2008-05-20\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2008-05-18, presumably until 2008-05-27\n- codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2008-05-22, presumably until 2008-05-22\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2008-05-23, presumably until 2008-05-24\n- dimethicone, through Topical route, started on 2008-05-20, presumably until 2008-05-20\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2008-05-27, presumably until 2014-05-19, with quantity of 60.0, with intended 5 refill(s). Instructions: take 400 mg by mouth 3 times a day. \n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2008-05-27, presumably until 2008-05-27\n- bisacodyl 5 MG Delayed Release Oral Tablet, through Oral route, started on 2008-05-25, presumably until 2008-05-25\n- voriconazole 200 MG Injection, through Intravenous route, started on 2008-05-23, presumably until 2008-05-27\n- diphenhydramine hydrochloride 2.5 MG/ML Oral Solution, through Oral route, started on 2008-05-19, presumably until 2008-05-20\n- heparin sodium, porcine 100 UNT/ML Injectable Solution, through Intravenous route, started on 2008-05-27, presumably until 2008-05-27\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2008-05-18, presumably until 2008-05-25\n- 1 ML meperidine hydrochloride 25 MG/ML Cartridge, started on 2008-05-24, presumably until 2008-05-24\n- lorazepam 1 MG Oral Tablet, through Oral route. Instructions: take 1 mg by mouth every 4 hours as needed \n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2008-05-18, presumably until 2008-05-24. Instructions: take 500 mg by mouth 2 times a day. \n- clotrimazole 10 MG Oral Lozenge, through Submucosal route, started on 2008-05-18, presumably until 2008-05-25. Instructions: by Mucous Membrane route 4 times a day. \n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2008-05-24, presumably until 2008-05-27\n- voriconazole 200 MG Oral Tablet, through Oral route, started on 2008-05-27, presumably until 2009-05-27, with quantity of 60.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- azithromycin 500 MG Oral Tablet, through Oral route, started on 2008-05-28, presumably until 2009-06-06, with quantity of 10.0, with intended 0 refill(s). Instructions: take 500 mg by mouth daily. \n- soybean oil 100 MG/ML Injectable Suspension, through Intravenous route, started on 2008-05-21, presumably until 2008-05-23\n- cefepime 2000 MG Injection, through Intravenous route, started on 2008-05-18, presumably until 2008-05-20\n- 50 ML immunoglobulin G, human 100 MG/ML Injection, through Intravenous route, started on 2008-05-23, presumably until 2008-05-23\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2008-05-18, presumably until 2008-05-24\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2008-05-19, presumably until 2008-05-20\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2008-05-21, presumably until 2008-05-21\n- 250 ML heparin sodium, porcine 100 UNT/ML Injection, through Intravenous route, started on 2008-05-18, presumably until 2008-05-23\n- 100 ML potassium chloride 0.2 MEQ/ML Injection, through Intravenous route, started on 2008-05-19, presumably until 2008-05-25\n- 72 HR scopolamine 0.0139 MG/HR Transdermal System, through Transdermal route, started on 2008-05-19, presumably until 2008-05-19\n- 72 HR fentanyl 0.05 MG/HR Transdermal System, through Transdermal route, started on 2008-05-21, presumably until 2008-05-21\n- petrolatum, through Topical route, started on 2008-05-20, presumably until 2008-05-20\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2008-05-19, presumably until 2008-05-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-05-29 13:30:00, ended at 2008-05-29 23:59:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 191 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.0 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.88 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-05-31 10:00:00, ended at 2008-05-31 23:59:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.90 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 45 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.2 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Basophils [#/volume] in Blood by Manual count: 0.0 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.91 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- MCV [Entitic volume] by Automated count: 93.4 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.2 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 39 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 1.7 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-05 00:00:00, ended at 2008-06-05 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.98 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 27.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 205 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.38 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.08 (million per microliter)\n- MCV [Entitic volume] by Automated count: 94.5 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.87 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-09 00:00:00, ended at 2008-06-09 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.01 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.6 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 54 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 10 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Manual count: 3.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- Monocytes [#/volume] in Blood by Manual count: 1.8 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 137 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 33 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-21 00:00:00, ended at 2008-06-21 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.06 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.10 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.17 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 170 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.8 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-03 00:00:00, ended at 2008-07-03 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.03 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.6 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- MCH [Entitic mass] by Automated count: 34.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 145 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 100.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 184 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.16 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.78 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-14 00:00:00, ended at 2008-07-14 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.1 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.37 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 191 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 101.5 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-20 00:00:00, ended at 2008-07-20 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.73 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.86 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.6 (percent)\n- MCH [Entitic mass] by Automated count: 35.5 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 102.0 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 195 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-28 00:00:00, ended at 2008-07-28 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.7 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.96 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.63 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- MCV [Entitic volume] by Automated count: 102.9 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 238 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-08-03 00:00:00, ended at 2008-08-03 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 214 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.20 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 102.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.93 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.6 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.7 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-08-16 00:00:00, ended at 2008-08-16 00:00:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 104.0 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.27 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 36.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.1 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.74 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 196 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-09-04 11:30:00, ended at 2008-09-04 23:59:00\nThe patient in this visit was 49 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- CD3 cells [#/volume] in Blood: 219 (per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- CD19 cells [#/volume] in Blood: 129 (per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.93 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 101.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 168 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.6 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.9 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- CD3 cells/100 cells in Blood: 46 (percent)\n- CD3+CD4+ (T4 helper) cells [#/volume] in Blood: 95 (per microliter)\n- CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood: 196 (per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- CD19 cells/100 cells in Blood: 27 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.90 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-07-02 00:00:00, ended at 2009-07-02 00:00:00\nThe patient in this visit was 50 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Multiple myeloma\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive their first ever diagnosis of Hyperlipidemia within the next year (we could not find any prior history of this condition in their medical records before)\n- the condition of hyperlipidemia means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "d335bcaa75bc1f3eeda3d57a3bdfd760f67565c67d5e0fe4ba38db425b81ef14", "prompt_hash": "e9af613d7d30bc0d7a57c5eeb8796dd654570161e29b864350c2b403de1fa669", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
